KR102059625B1 - Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality - Google Patents

Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality Download PDF

Info

Publication number
KR102059625B1
KR102059625B1 KR1020180164289A KR20180164289A KR102059625B1 KR 102059625 B1 KR102059625 B1 KR 102059625B1 KR 1020180164289 A KR1020180164289 A KR 1020180164289A KR 20180164289 A KR20180164289 A KR 20180164289A KR 102059625 B1 KR102059625 B1 KR 102059625B1
Authority
KR
South Korea
Prior art keywords
spc
snu
lactic acid
activity
lactobacillus plantarum
Prior art date
Application number
KR1020180164289A
Other languages
Korean (ko)
Inventor
서진호
한남수
강신달
이덕범
Original Assignee
에스피씨 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스피씨 주식회사 filed Critical 에스피씨 주식회사
Priority to KR1020180164289A priority Critical patent/KR102059625B1/en
Application granted granted Critical
Publication of KR102059625B1 publication Critical patent/KR102059625B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00Methods for preparing or baking dough
    • A21D8/02Methods for preparing dough; Treating dough prior to baking
    • A21D8/04Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • C12R1/25
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, antimicrobial activity, immunomodulatory activity, and baking quality. The probiotic lactic acid bacteria of the present invention has especially outstanding biotransformation enzyme activity, antimicrobial activity, and acid resistance, and also has excellent intestinal attachment and immune activity. When the probiotic lactic acid bacteria of the present invention is kneaded and fermented with baking yeast, bread having improved bread properties and flavor, extended expiration date, and high survival rate and probiotic activity can be manufactured.

Description

생물전환효소활성, 항균활성, 면역 조절 활성 및 제빵 적성이 우수한 프로바이오틱 유산균 {Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality}Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality}

본 발명은 프로바이오틱 유산균에 관한 것으로, 더욱 구체적으로 생물전환효소활성, 항균 활성, 면역 조절 활성 및 제빵 적성이 우수한 프로바이오틱 유산균에 관한 것이다.The present invention relates to probiotic lactic acid bacteria, and more particularly to probiotic lactic acid bacteria, which have excellent bioconversion enzyme activity, antimicrobial activity, immunomodulatory activity and baking ability.

유산균으로 대표되는 프로바이오틱스는 위산과 담즙에 관한 내성을 가져, 섭취시 소화기를 통하여 장에 도달한 후, 정착하여 장내세균총의 균형을 유지하고, 단쇄지방산을 생성하며, 건강에 유익한 영향을 주는 것으로 알려졌다. 또한, 프로바이오틱스는 유해균의 생육을 억제하고, 면역활성을 조절하여 다양한 건강기능을 제공하는 것으로 알려졌다. 특히, 유산균은 발효 식품에서 흔히 찾아볼 수 있는 균사체로, 발효 식품인 요구르트, 김치, 낫토 등에 많이 포함되어 있으며, 젖산균이라고도 한다. 대표적인 유산균으론 락토바실러스 카제이(Lb. casei), 락토바실러스 애시도필러스(Lb.acidophilus), 락토바실러스 불가리쿠스(Lb.bulgaricus), 비피도박테리움 비피덤(B. bifidum) 등이 있다. Probiotics, represented by lactic acid bacteria, are known to have resistance to gastric acid and bile, to reach the intestine through the digestive organs when ingested, settle, balance the intestinal bacterial flora, produce short-chain fatty acids, and have a beneficial effect on health. . In addition, probiotics are known to inhibit the growth of harmful bacteria and to provide a variety of health functions by regulating immune activity. In particular, lactic acid bacteria are mycelia commonly found in fermented foods, which are contained in fermented foods such as yogurt, kimchi, natto, and also called lactic acid bacteria. Representative lactic acid bacteria include Lactobacillus casi ( Lb. casei ), Lactobacillus ashdophyllus ( Lb.acidophilus ), Lactobacillus vulgaricus ( Lb.bulgaricus ), Bifidobacterium bifidum ( B. bifidum ) and the like.

프로바이오틱스 유산균의 주된 건강기능 중 한 가지는 면역조절기능이며 장내에서 유산균이 생성한 초산(acetic acid), 프로피온산(propionic acid), 부틸산(butylic acid)과 같은 단쇄지방산에 의한 면역시스템의 활성화와 유산균 균체의 세포벽 성분인 다당체에 의한 장내 상피조직의 수지상세포 자극에 의한 기작이 알려졌다. 특히 세포벽 다당체에 의한 면역조절 기능은 생균(live cells)뿐만 아니라 사균(dead cells)에서도 유사한 수준으로 나타나는 것으로 알려져 사균 섭취에 의한 면역조절기능은 잠재적으로 중요한 건강 유지 수단으로 간주되고 있다. 국내에서는 유산균 사균체의 항균활성을 바탕으로 설사치료를 위한 원료의약품으로 사용되고 있고, 일본에서는 꽃가루 알러지 등 면역 관련 효능으로 사균체 제품이 개발되었다. 그 예로 일본에서 출시된 “FK-23”제품은 유산균을 열처리한 사균체로 구성되며 면역활성 기능으로 C형 간염 치료제이고, “acidophilus L-92”균주의 사균체도 면역 조절 활성을 제공하는 제품으로 개발되었다. One of the main health functions of probiotic lactic acid bacteria is immunomodulatory function and activation of immune system and short-chain fatty acids such as acetic acid, propionic acid and butylic acid produced by lactic acid bacteria in the intestine The mechanism by which dendritic cell stimulation of intestinal epithelial tissue is induced by polysaccharide, a cell wall component of, has been known. In particular, the immunomodulatory function by cell wall polysaccharides is shown to be similar levels in dead cells as well as live cells, and immunoregulatory function by ingesting dead cells is considered as a potentially important health maintenance means. Based on the antimicrobial activity of Lactobacillus microorganisms, it is used as a raw material for diarrhea treatment. In Japan, a microbial product was developed for immune-related effects such as pollen allergy. For example, the "FK-23" product released in Japan is composed of microorganisms heat-treated with lactic acid bacteria, and hepatitis C treatment as an immune-activating function, and the microorganisms of the "acidophilus L-92" strain also provide immune regulation Was developed.

면역 반응은 크게 선천성 면역(innate immunity)과 적응면역(adaptive immunity)으로 구분한다. 선천성 면역은 대식세포(macrophages)와 수지상 세포(dendritic cells)가 관여하여 항원을 비특이적으로 인식 후 제거하는 과정인 반면, T-세포와 B-세포로 대표되는 적응면역 세포는 특이적으로 항원과 반응한다. 항원제시세포(antigen-presenting cells)로는 B-세포, 대식세포, 수지상 세포가 있는데, 이들은 항원을 포획 후 분해하여 주조직적합성 복합체(major histocompatibility complex, MHC)를 통해 세포표면에 항원 펩티드를 제시하고, T-세포의 수용체에 구조정보를 전달한다. Immune responses are largely divided into innate immunity and adaptive immunity. Innate immunity is a process in which macrophages and dendritic cells engage in nonspecific recognition and removal of antigens, whereas adaptive immune cells, represented by T- and B-cells, specifically react with antigens. do. Antigen-presenting cells include B-cells, macrophages, and dendritic cells, which capture and degrade antigens to present antigenic peptides on the cell surface through major histocompatibility complex (MHC). It delivers structural information to T-cell receptors.

항원을 포획 후 활성화된 항원제시세포는 CD80, CD86, CD40과 같은 분자들의 발현을 유도하고 이들은 다시 T-세포의 활성화와 항원제시세포의 활성에 작용한다. 예를 들어 B-세포와 활성화된 보조 T-세포 사이에 있는 CD40/CD40 결합을 통해 B-세포는 항체 IgM을 생성하다가 IgA, IgG, IgE로 생성반응이 변경될 수 있다. 활성화된 보조 T-세포는 존재하는 사이토카인에 따라서 Th1과 Th2 세포로 분화된다. 대식세포와 수지상세포가 미생물을 인식하고 사이토카인인 IL-12, IL-6, TNF-α을 분비하면 활성화된 보조 T-세포는 Th1 세포로 분화하고 IFN-γ:IL-4의 분비비율이 증가한다. 반대로 미생물에 의한 자극이 없으면 사이토카인은 활성화된 보조 T-세포를 Th2 세포로 분화되도록 유도하고 IFN-γ:IL-4의 분비비율은 감소하게 되어 결과적으로 B세포가 IgE를 생성하도록 유도한다. After capturing the antigen, the activated antigen-presenting cells induce the expression of molecules such as CD80, CD86, CD40, which in turn act on T-cell activation and antigen-presenting cell activity. For example, through CD40 / CD40 binding between B-cells and activated helper T-cells, B-cells produce antibody IgM, which can be altered by IgA, IgG, or IgE. Activated helper T-cells differentiate into Th1 and Th2 cells depending on the cytokines present. When macrophages and dendritic cells recognize microorganisms and secrete the cytokines IL-12, IL-6, and TNF-α, activated adjuvant T-cells differentiate into Th1 cells and the secretion ratio of IFN-γ: IL-4 Increases. Conversely, without microbial stimulation, cytokines induce activated secondary T-cells to differentiate into Th2 cells and the secretion rate of IFN-γ: IL-4 decreases, resulting in B cells producing IgE.

이렇게 Th2 세포로 분화되는 경로는 IL-12 자극 신호가 없을 경우에 기본적으로 진행되는 것으로 알려졌다. IgE 항체는 외부생물 감염시 꼭 필요한 방어수단이나 과도한 분비는 점막층에서 비만세포가 염증성 매개체를 분비하여 아토피, 비염, 가래 등과 같은 알러지 증상을 일으킨다. 잘 알려진 ‘위생 이론(hygiene theory)’에 의하면 적절한 미생물의 자극이 없으면 IL-12를 생성하는 선천면역 세포의 활성이 떨어지고 Th2 세포가 과도하게 활성화 되어 IgE 생성이 촉진되고 알러지 증상이 증가하는 것으로 관찰된다. 결과적으로, Th1과 Th2 세포는 서로 길항 작용을 일으키기 때문에, Th2 세포의 과도한 면역 반응에 의해 유발되는 알러지의 치료는 Th1 세포에 의한 면역 반응을 유발시켜 질병을 치료하려는 치료법이 개발되고 있다.This differentiation pathway to Th2 cells is known to proceed basically in the absence of IL-12 stimulation signals. IgE antibodies are a necessary defense against external organism infection, but excessive secretion causes allergic symptoms such as atopy, rhinitis and sputum by mast cells secreting inflammatory mediators from the mucosal layer. According to the well-known hygiene theory, without proper microbial stimulation, the innate immune cells that produce IL-12 are reduced, and Th2 cells are excessively activated to promote IgE production and increase allergic symptoms. do. As a result, since Th1 and Th2 cells antagonize each other, the treatment of allergy caused by excessive immune response of Th2 cells has been developed to treat diseases by inducing an immune response by Th1 cells.

한편, 유산균은 제빵기술에 활발히 이용되는데, 효모와 유산균을 함께 밀가루 반죽에서 발효시키면 빵의 부피 증가, 물성 개선, 풍미향상, 유통기한 연장 등 다양한 장점을 제공한다. 이러한 사워도우(Sourdough) 발효기술은 산성반죽 발효기술이라고도 하며 일반적으로 밀가루, 물, 호밀가루를 섞어 제조하며, 효모와 유산균이 각각 알코올과 젖산을 생성하여 빵에 풍미를 부여하고 기호성을 향상시킨다. 사워도우 발효와 관련된 유산균으로는 스트렙토코쿠스(Streptococcus) 속, 페디오코쿠스(Pediococcus) 속, 락토바실러스(Lactobacillus) 속, 류코노스톡(Leuconostoc) 속, 바이셀라(Weissella) 속 등이 알려져 있다. 한편, 자연 발효법에 의존하는 전통적인 사워도우 빵(sourdough bread)은 작업 환경에서 유래하는 다양한 종류의 세균이 오염되어 풍미가 나빠지거나 산패취 등이 발생하는 문제점이 발생한다. 또한, 공간과 시간적 차이에 의해 균등한 품질의 제품을 재현하는데 어려움이 있다. On the other hand, lactic acid bacteria are actively used in baking technology, fermenting yeast and lactic acid bacteria together in flour dough provides a variety of advantages, such as increased bread volume, improved physical properties, improved flavor, extended shelf life. This sourdough fermentation technology, also known as acid kneading fermentation technology, is generally manufactured by mixing flour, water, and rye flour. Yeast and lactic acid bacteria produce alcohol and lactic acid, respectively, to give flavor to bread and improve palatability. Lactic acid bacteria related to sourdough fermentation are known as Streptococcus genus, Pediococcus genus, Lactobacillus genus, Leuconostoc genus and Weissella genus. On the other hand, traditional sourdough bread (depending on the natural fermentation method) has a problem that the various kinds of bacteria derived from the working environment is contaminated, resulting in poor flavor or rancid odor. In addition, there is a difficulty in reproducing an equal quality product due to space and time difference.

따라서, 자연 발효빵의 오염 기회 회피와 균등한 품질을 확보하고자 기능성과 안전성이 확보된 유산균 스타터(starter)를 반죽에 첨가하는 것이 필요하다. 이미 일부 국내 제빵 업체에서는 이를 위해 수입한 스타터(starter)를 사용하고 있으나 강한 산미를 제공하여 국내 소비자의 제빵 기호도에 적합하지 않거나 계대 배양 도중 균주 특성이 쉽게 변화하는 문제점이 관찰된다. 따라서, 한국인의 기호도에 적합하면서 제빵현장에 안정적으로 사용할 수 있는 스타터의 개발이 필요한 실정이다. 더불어, 사균(dead cells)으로 섭취 후 장내에서 면역조절활성을 보이는 유산균을 스타터로 사용한다면 제빵 적성과 건강 기능성을 동시에 제공할 수 있다.Therefore, it is necessary to add lactic acid bacteria starter (starter) secured functionality and safety to the dough in order to avoid the opportunity of contamination of natural fermented bread and to ensure the equivalent quality. Some domestic bakeries already use imported starters for this purpose, but they provide strong acidity, which is not suitable for the baking preference of domestic consumers, or strain characteristics are easily changed during subculture. Therefore, it is necessary to develop a starter that is suitable for Korean taste and can be used stably at a baking site. In addition, lactic acid bacteria showing immunomodulatory activity in the intestine after ingestion into dead cells can be used to provide both baking aptitude and health functionality.

대한민국등록특허 제10-1551836호(2015.09.03)에는, 한국 전통 누룩으로부터 분리한 제빵용 신규의 토종 천연 유산균에 관하여 기재되어 있다.Korean Patent Registration No. 10-1551836 (2015.09.03) describes a new native natural lactic acid bacteria for baking isolated from Korean traditional yeast. 대한민국등록특허 제10-1551837호(2015.09.03)에는, 한국 전통 누룩으로부터 분리한 제빵용 신규의 토종 천연 유산균에 관하여 기재되어 있다.Korean Patent Registration No. 10-1551837 (2015.09.03) describes a new native natural lactic acid bacteria for baking isolated from Korean traditional yeast.

본 발명은 생물전환효소활성, 항균활성, 면역 조절 활성 및 제빵 적성이 우수한 프로바이오틱 유산균을 발굴하여 제공하고자 한다.The present invention is to discover and provide probiotic lactic acid bacteria excellent in bioconversion enzyme activity, antimicrobial activity, immunomodulatory activity and baking aptitude.

본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)을 제공한다.The present invention provides Lactobacillus plantarum SPC-SNU 72-3 (KCTC13316BP).

한편, 본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)을 밀가루에 첨가한 후 발효시켜 제조된 것을 특징으로 하는 제빵용 반죽물을 제공한다.On the other hand, the present invention provides a dough for baking, characterized in that the Lactobacillus plantarum ( Lactobacillus plantarum ) SPC-SNU 72-3 (KCTC13316BP) is added to the flour and then fermented.

한편, 본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)을 밀가루에 첨가한 후 발효시키고, 베이킹(baking)하여 제조된 것을 특징으로 하는 빵을 제공한다.On the other hand, the present invention provides Lactobacillus plantarum ( Lactobacillus plantarum ) SPC-SNU 72-3 (KCTC13316BP) is added to the flour, fermented, and provides a bread characterized in that it is produced by baking.

본 발명의 프로바이오틱 유산균은 생물전환효소활성, 항균활성, 내산성이 특히 우수하고, 그 외에 장부착능 및 면역활성이 우수하다. 본 발명의 프로바이오틱 유산균을 제빵효모와 함께 반죽 발효시, 빵의 물성, 향미, 유통기간을 개선하고, 높은 생존율 및 프로바이오틱 활성을 가지는 빵을 제조할 수 있다.The probiotic lactic acid bacteria of the present invention are particularly excellent in bioconverting enzyme activity, antibacterial activity and acid resistance, in addition to excellent intestinal adhesion and immune activity. When the probiotic lactic acid bacteria of the present invention and the dough fermentation together with the baker's yeast, it is possible to improve the properties, flavor, shelf life of the bread, and to produce bread having a high survival rate and probiotic activity.

도 1은 김치로부터 분리한 균주들의 락토바실러스 플란타룸 (Lactobacillus plantarum) specific PCR을 수행한 결과이다.
도 2는 본 발명 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 및 공시균주 2종에 대해 바이오제닉아민 생성능이 있는지 확인한 결과이다.
도 3은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3 및 공시균주(Lb. reuteri KCCM40717)의 용혈현상을 측정한 결과이다.
도 4는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 pH에 따른 산 내성을 비교한 결과이다.
도 5는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 담즙 농도에 따른 유산균의 담즙내성을 비교한 결과이다.
도 6은 대장 상피세포 Caco-2 세포를 이용해 장내 부착능을 평가한 결과이다.
도 7은 글루코오스를 포함하지 않는 플랜트 글리코사이드(plant glycoside) 함유배지에서의 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 생장곡선을 나타낸 결과이다.
도 8은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3 균주의 효소 활성을 나타낸 그래프이다.
도 9는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 베타-글리코시데이즈 효소에 의한 진세노사이드(Ginsenoside) Rb1 생물전환을 보여주는 TLC결과이다 (GM: ginsenoside mixtures, 1: Rb1 reacted with beta-glucosidase from Lb. plantarum SPC-SNU 72-3 cultured in glucose-MRS medium, 2: Rb1 reacted with beta-glucosidase from Lb. plantarum SPC-SNU 72-3 cultured in amygdalin-MRS medium).
도 10은 말토오스 배지에서 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 배양학적 특성을 나타낸 결과이다.
도 11은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 말토오스 이용능을 확인한 결과이다.
도 12는 공시균주로 사용한 락토바실러스 플란타룸 KACC11451가 적용된 빵, 락토바실러스 플란타룸의 상업균주인 Lallemand L73이 적용된 빵, 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3이 적용된 빵의 사진이다.
도 13은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3, 상업균주인 Lallemand L73, 공시균주로 사용한 락토바실러스 플란타룸 KACC11451가 각각 적용된 본종의 가스 발생력을 확인한 결과이다.
도 14는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3이 적용된 빵의 노화 속도를 측정한 결과이다.
도 15는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3이 적용된 빵 (시료) 1g당 검출된 휘발성 향기성분 (alcohol, aldehyde, ketone, acid 류 등)의 전체적인 정량적 수치를 비교한 결과이다.
1 is a result of performing the Lactobacillus plantarum specific PCR of the strains isolated from kimchi.
Figure 2 shows the results of confirming the biogenic amine generation ability for the present invention Lactobacillus plantarum ( Lactobacillus plantarum ) SPC-SNU 72-3 and two strains.
Figure 3 is the result of measuring the hemolysis of the Lactobacillus plantarum SPC-SNU 72-3 and the strain ( Lb. reuteri KCCM40717) of the present invention.
Figure 4 is a result of comparing the acid resistance according to the pH of the present invention Lactobacillus plantarum SPC-SNU 72-3.
5 is a result of comparing the bile resistance of lactic acid bacteria according to the bile concentration of the present invention Lactobacillus plantarum SPC-SNU 72-3.
6 is a result of evaluating intestinal adhesion capacity using colon epithelial cells Caco-2 cells.
Figure 7 shows the growth curve of the present invention Lactobacillus plantarum SPC-SNU 72-3 in plant glycoside-containing medium that does not contain glucose.
8 is a graph showing the enzymatic activity of the Lactobacillus plantarum SPC-SNU 72-3 strain of the present invention.
9 is a TLC showing Ginsenoside Rb1 bioconversion by beta-glycosidase enzyme of the present invention Lactobacillus plantarum SPC-SNU 72-3 (GM: ginsenoside mixtures, 1: Rb1 reacted with beta-glucosidase from Lb.plantarum SPC-SNU 72-3 cultured in glucose-MRS medium, 2: Rb1 reacted with beta-glucosidase from Lb.plantarum SPC-SNU 72-3 cultured in amygdalin-MRS medium).
10 is a result showing the culture characteristics of the Lactobacillus plantarum SPC-SNU 72-3 of the present invention in maltose medium.
11 is a result confirming the maltose capacity of the present invention Lactobacillus plantarum SPC-SNU 72-3.
12 is a bread to which the Lactobacillus plantarum KACC11451 is applied as a test strain, a bread to which Lallemand L73, a commercial strain of Lactobacillus plantarum, is applied, and a bread to which the present invention Lactobacillus plantarum SPC-SNU 72-3 is applied. to be.
13 is a result of confirming the gas generating power of the present species to which the present invention Lactobacillus plantarum SPC-SNU 72-3, a commercial strain Lallemand L73, a lactobacillus plantarum KACC11451 used as a test strain.
14 is a result of measuring the aging rate of the bread to which the present invention Lactobacillus plantarum SPC-SNU 72-3 is applied.
FIG. 15 is a result of comparing quantitative values of volatile aromatic components (alcohol, aldehyde, ketone, acid, etc.) detected per 1g of bread (sample) to which the present invention Lactobacillus plantarum SPC-SNU 72-3 is applied.

본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)을 제공한다. 상기 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)은 김치로부터 분리한 신규의 유산균으로서, 생물전환효소활성 및 내산성이 특히 우수하고, 그 외에 항균 활성, 장부착능 및 면역활성이 우수한 특징이 있다. 또한, 제빵에 적용시 제빵 적성 또한 우수한 것으로 나타났다. The present invention provides Lactobacillus plantarum SPC-SNU 72-3 (KCTC13316BP). The Lactobacillus plantarum SPC-SNU 72-3 (KCTC13316BP) is a novel lactic acid bacterium isolated from kimchi, and is particularly excellent in bioconversion enzyme activity and acid resistance, in addition to antibacterial activity, intestinal adhesion and immunity. It is characterized by excellent activity. In addition, baking aptitude was also excellent when applied to baking.

한편, 본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)를 밀가루에 첨가한 후 발효시켜 제조된 것을 특징으로 하는 제빵용 반죽물을 제공한다. 김치로부터 분리한 신규의 유산균인 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)이 첨가된 밀가루 반죽은 초기 가스 발생력이 대조구보다 현저히 우수하여 제빵용으로 적합하다.On the other hand, the present invention provides a dough for baking, characterized in that the Lactobacillus plantarum ( Lactobacillus plantarum ) SPC-SNU 72-3 (KCTC13316BP) is added to the flour and then fermented. The flour dough added with Lactobacillus plantarum SPC-SNU 72-3 (KCTC13316BP), a novel lactic acid bacterium isolated from kimchi, is well suited for baking since its initial gas generating ability is significantly better than that of the control.

한편, 본 발명은 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)를 밀가루에 첨가한 후 발효시키고, 베이킹(baking)하여 제조된 것을 특징으로 하는 빵을 제공하는데, 상기 베이킹(baking)은 굽는 것을 의미한다. 상기와 같이 제조된 빵은 상업 이스트로 제조된 빵보다 빵의 식감이 부드럽고, 경도가 낮으며 노화속도가 느려 저장성이 우수하다. 또한, 기호도가 우수한 향기 성분을 발산하여 풍미가 좋다.Meanwhile, the present invention provides Lactobacillus plantarum SPC-SNU 72-3 (KCTC13316BP) to flour, and then fermented and baked to provide bread, which is prepared by baking. Baking means baking. Bread prepared as described above has a softer texture, breadth of hardness and a slower aging rate than the bread produced in commercial yeast is excellent storage. Moreover, the flavor is good by releasing the fragrance component excellent in preference.

이하, 본 발명의 내용을 하기 실시예 또는 실험예를 통해 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예 또 실험예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다.Hereinafter, the content of the present invention will be described in more detail through the following examples or experimental examples. However, the scope of the present invention is not limited only to the following Examples and Experimental Examples, but includes modifications of equivalent technical ideas.

<< 실시예Example 1: One: 본 발명 The present invention 프로바이오틱Probiotic 유산균의 분리 및 동정> Isolation and Identification of Lactic Acid Bacteria>

(1)(One) 유산균 분리Lactic acid bacteria isolated

김치 10g, 0.85% NaCl 90㎖를 여과포(filter bag)에 담아 스토마커(stomacher)를 이용해 3분간 균질화하였다. 이를 다시 0.85% NaCl로 단계적 희석을 통해 적절한 농도로 희석한 후, 0.01% 사이클로헥사미드(cycloheximide), BPB(Bromophenol blue)가 첨가된 MRS(de Man Rogosa and Sharpe, Difco) 고체배지에 도말하여 분리하였다. 유산균이 생성하는 산에 의하여 콜로니 색이 변하는 특성을 이용하여 균주를 선택적으로 선발하기 위하여, 기존의 MRS 배지에 브로모페놀블루(Bromophenol-blue)를, 진균 억제를 위하여 사이클로헥사미드(cycloheximide)를 첨가하였다. 배양조건은 30℃에서 48시간 동안 혐기 배양하였고, 가운데 진한 파란색원을 가진 흰색 콜로니를 락토바실러스 플란타룸(Lactobacillus plantarum)후보 균주로 간주하고 순수분리 배양을 하였다.10 g of kimchi and 90 ml of 0.85% NaCl were placed in a filter bag and homogenized for 3 minutes using a stomacher. Dilution was carried out in steps of 0.85% NaCl to the appropriate concentration, followed by plating on MRS (de Man Rogosa and Sharpe, Difco) solid medium containing 0.01% cycloheximide and BPB (Bromophenol blue). It was. In order to selectively select strains using the characteristic of colony color change by the acid produced by lactic acid bacteria, bromophenol-blue was added to the existing MRS medium, and cycloheximide was used to suppress fungi. Added. Culture conditions were anaerobic culture for 48 hours at 30 ℃, the white colony with a dark blue circle was considered to be Lactobacillus plantarum candidate strain and purely isolated culture.

(2)(2) 락토바실러스Lactobacillus 플란타룸Planta Room 동정 Sympathy

락토바실러스 플란타룸에 특이적인 프라이머는 나오키 카토 박사의 논문(Naoki Kato, 2000, Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S 23S rRNA intergenic spacer region and its flanking 23S rRNA)을 참조하여 디자인된 LplanF(5'-ATTCATAGTCTAGTTGGAGGT-3'), LplanR(5'- CCTGAACTGAGAGAATTTGA-3')을 이용하였으며, 증폭사이즈는 248bp이고, 95℃에서 3분간 프리-디네튜어레이션(pre-denaturation), 95℃에서 30초간, 60℃에서 30초간, 72℃에서 30초간 진행하는 것을 1사이클로 하여, 30사이클을 진행하고, 최종 신장을 위하여 72℃에서 5분간 PCR을 수행한 후, 전기영동하여 PCR 결과를 확인하였다 (도 1). 도 1은 김치로부터 분리한 균주들의 락토바실러스 플란타룸 (Lactobacillus plantarum) specific PCR을 수행한 결과이다. 실험 결과, 36종의 균주에서 248bp의 밴드가 형성되었고, 16S rRNA 서열 분석 결과 락토바실러스 플란타룸(Lactobacillus plantarum)으로 동정되었다. 이렇게 분리한 균주를 SPC-SNU 72-3이라 명명하였고, 한국생명공학연구원에 기탁하여 2017년 8월 24일자로 기탁번호 'KCTC13316BP'을 부여받았다.Primers specific for Lactobacillus plantarum can be found in Dr. Naoki Kato, 2000, Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S 23S rRNA intergenic spacer region. LplanF (5'-ATTCATAGTCTAGTTGGAGGT-3 ') and LplanR (5'- CCTGAACTGAGAGAATTATTGA-3') designed with reference to its flanking 23S rRNA) were used and the amplification size was 248 bp, pre-dine at 95 ° C for 3 minutes. 30 cycles of pre-denaturation, 30 seconds at 95 ° C., 30 seconds at 60 ° C., and 30 seconds at 72 ° C., followed by 30 cycles, and PCR was performed at 72 ° C. for 5 minutes for final elongation. After the electrophoresis, the PCR result was confirmed (FIG. 1). Figure 1 shows the results of performing the Lactobacillus plantarum specific PCR of the strains isolated from kimchi. As a result, bands of 248 bp were formed in 36 strains, and 16S rRNA sequencing was identified as Lactobacillus plantarum . The isolated strain was named SPC-SNU 72-3, and was deposited with the Korea Research Institute of Bioscience and Biotechnology and received the accession number 'KCTC13316BP' on August 24, 2017.

(3)(3) 락토바실러스Lactobacillus 플란타룸의Plantarum 생화학적 특성 Biochemical properties

상기에서 분리한 분리균주(SPC-SNU 72-3), 공시균주(KACC11451), 상업균주(Lallemand L73)의 당 이용 특성을 API50CH와 API 50CHL 키트(Biomerieux사)를 이용하여 분석하였고, 하기 표 1에 나타내었다. 실험 결과, 분리균주(SPC-SNU 72-3)는 공시균주 및 상업균주와 비교할 때, 엘-아라비노스(L-arabinose), 디-소르비톨(D-sorbitol), 디-락토오스(D-lactose), 이눌린(Inulin), 디-튜라노스(D-turanose) 및 D-아라비톨(D-arabitol)대사에서 차이를 보이는 신규균주로 판명되었다.The sugar use characteristics of the isolated strain (SPC-SNU 72-3), the strain (KACC11451), and the commercial strain (Lallemand L73) were analyzed using API50CH and API 50CHL kit (Biomerieux). Shown in As a result, the isolated strain (SPC-SNU 72-3) was compared with the test strain and the commercial strain, L-arabinose, L-arabinose, D-sorbitol, and D-lactose. , Inulin, D-turanose and D-arabitol were found to be new strains with differences.

락토바실러스 플란타룸 SPC-SNU 72-3의 당 이용 특성 분석결과Analysis of sugar utilization characteristics of Lactobacillus plantarum SPC-SNU 72-3 SPC-SPC- SNUSNU 72-3 72-3 공시균주Disclosure strain KACC11451 KACC11451 상업균주 Commercial strain
LallemandLallemand L73 L73
controlcontrol -- -- -- GlycerolGlycerol -- -- -- ErythriolErythriol -- -- -- D-arabinoseD-arabinose -- -- -- L-arabinoseL-arabinose -- ++ ++ D-riboseD-ribose ++ ++ ++ D-xyloseD-xylose -- -- -- L-xyloseL-xylose -- -- -- D-adonitolD-adonitol -- -- -- Methyl-βD-xylopyranosideMethyl-βD-xylopyranoside -- -- -- D-galactoseD-galactose ++ ++ ++ D-glucoseD-glucose ++ ++ ++ D-fructoseD-fructose ++ ++ ++ D-mannoseD-mannose ++ ++ ++ L-sorboseL-sorbose -- -- -- L-rhamnoseL-rhamnose -- -- -- DulcitolDulcitol -- -- -- InositolInositol -- -- -- D-mannitolD-mannitol ++ ++ ++ D-sorbitolD-sorbitol -- ++ ++ Methyl-α-D-mannopyranosideMethyl-α-D-mannopyranoside ++ ++ ++ Methyl-α-D-gucopyranosideMethyl-α-D-gucopyranoside -- -- -- N-acetylglucosamineN-acetylglucosamine ++ ++ ++ AmygdalinAmygdalin ++ ++ ++ ArbutinArbutin ++ ++ ++ EsculinEsulin ++ ++ ++ SalicinSalicin ++ ++ ++ D-celiobioseD-celiobiose ++ ++ ++ D-maltoseD-maltose ++ ++ ++ D-lactoseD-lactose -- ++ ++ D-melibioseD-melibiose ++ ++ ++ D-saccharoseD-saccharose ++ ++ ++ D-trehaloseD-trehalose ++ ++ ++ InulinInulin ++ -- -- D-melezitoseD-melezitose ++ ++ ++ D-raffinoseD-raffinose ++ ++ ++ AmidonAmidon -- -- -- GlycogenGlycogen -- -- -- XylitolXylitol -- -- -- GentiobioseGentiobiose ++ ++ ++ D-turanoseD-turanose -- ++ ++ D-lyxoseD-lyxose -- -- -- D-tagatoseD-tagatose -- -- -- D-fucoseD-fucose -- -- -- L-fucoseL-fucose -- -- -- D-arabitolD-arabitol ++ -- -- L-arabitolL-arabitol -- -- -- Potassium gluconatePotassium gluconate ++ ++ ++ Potassium 2-ketogluconatePotassium 2-ketogluconate -- -- -- Potassium 5-ketogluconatePotassium 5-ketogluconate -- -- --

<< 실험예Experimental Example 1: One: 본 발명 The present invention 프로바이오틱Probiotic 유산균의 인체 장내 안전성 분석> Human Intestinal Safety Analysis of Lactic Acid Bacteria>

(1)(One) 바이오제닉아민Biogenic amine 생성능Generating ability 확인 Confirm

바이오제닉 아민(Biogenic amines)은 발효식품에서 미생물에 의해 생성되며 식중독을 유발하는데, 이에 대한 안전성을 검증하기 위해 엠마누엘 코튼(Emmanuel Coton)의 논문(Multiplex PCR for colony direct detection of Gram-positive histamine- and tyramine-producing bacteria)을 참고하여, HDC3 (5'-GATGGTATTGTTTCKTATGA-3') and HDC4 (5'-CAAACACCAGCATCTTC-3'), TD2 (5'-ACATAGTCAACCATRTTGAA-3') and TD5 (5'-CAAATGGAAGAAGAAGTAGG-3')을 사용하였고, 각각 증폭사이즈는 1182bp, 436bp이며, 95℃에서 3분간 프리-디네튜어레이션(pre-denaturation), 95℃에서 30초간, 52℃에서 30초간, 72℃에서 90초간 진행하는 것을 1 사이클로 하여, 30 사이클을 진행하고, 최종 신장을 위하여 72℃에서 5분간 multiplex PCR을 수행한 후, 전기영동하여 PCR 결과를 확인하였다 (도 2). 도 2는 본 발명 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 및 공시균주 2종에 대해 바이오제닉아민 생성능이 있는지 확인한 결과이다. 실험 결과, 분리한 락토바실러스 플란타룸 SPC-SNU 72-3의 경우 바이오제닉 아민에 속하는 2종(tyramine, histamine)을 생성하는 유전자를 갖고 있지 않는 것으로 확인되었다.Biogenic amines are produced by microorganisms in fermented foods and induce food poisoning.To verify their safety, Multiplex PCR for colony direct detection of Gram-positive histamine- and tycamine-producing bacteria), HDC3 (5'-GATGGTATTGTTTCKTATGA-3 ') and HDC4 (5'-CAAACACCAGCATCTTC-3'), TD2 (5'-ACATAGTCAACCATRTTGAA-3 ') and TD5 (5'-CAAATGGAAGAAGAAGTAGG-3 '), And the amplification size is 1182bp, 436bp, respectively, pre-denaturation for 3 minutes at 95 ℃, 30 seconds at 95 ℃, 30 seconds at 52 ℃, 90 seconds at 72 ℃ 1 cycle, 30 cycles, multiplex PCR for 5 minutes at 72 ℃ for final elongation, electrophoresis was confirmed by the PCR results (Fig. 2). Figure 2 shows the results of confirming the biogenic amine generation ability for the present invention Lactobacillus plantarum ( Lactobacillus plantarum ) SPC-SNU 72-3 and two strains. As a result, it was confirmed that the isolated Lactobacillus plantarum SPC-SNU 72-3 does not have a gene for generating two kinds (tyramine, histamine) belonging to the biogenic amine.

(2)(2) 용혈현상측정Hemolysis

유산균은 일반적으로 안전하다고 알려졌으나, 병원성이 있는 유산균이 보고되고 있어 신규 유산균들에 대한 안전성 검증이 요구되고 있다. 안전성을 검증하기 위해 한국바이오벤처협회 단체표준(유산균의 용혈 현상 측정 방법)을 참고하여 5% 면양혈액을 첨가한 TSA(Tryptic Soy Agar) 또는 BHI(Brain Heart Infusion) 배지에 측정대상 유산균을 접종하여 30℃에서 48시간 배양한 후 배지 상에 나타나는 용혈현상을 확인하였다 (도 3). 도 3은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3 및 공시균주(Lb. reuteri KCCM40717)의 용혈현상을 측정한 결과이다.Lactic acid bacteria are generally known to be safe, but pathogenic lactic acid bacteria have been reported, so the safety verification of new lactic acid bacteria is required. To verify the safety, refer to the Korea Bio Venture Association's group standard (Method for measuring hemolysis of lactobacillus) and inoculate the Lactobacillus to be measured on TSA (Tryptic Soy Agar) or BHI (Brain Heart Infusion) medium containing 5% sheep blood. After incubation at 30 ° C. for 48 hours, hemolysis was observed on the medium (FIG. 3). Figure 3 is the result of measuring the hemolysis of the Lactobacillus plantarum SPC-SNU 72-3 and the strain ( Lb. reuteri KCCM40717) of the present invention.

실험 결과, 락토바실러스 플란타룸 SPC-SNU 72-3 및 공시균주(Lb. reuteri KCCM40717) 모두에서 용혈현상이 나타나지 않았고, 배지의 색깔 변화도 없어 비병원성인 γ용혈(무색)로 판단되었다.As a result, hemolysis was not observed in both Lactobacillus plantarum SPC-SNU 72-3 and the test strain ( Lb. reuteri KCCM40717), and there was no change in the color of the medium, which was judged as γ hemolysis (colorless).

<< 실험예Experimental Example 2: 2: 본 발명 The present invention 프로바이오틱Probiotic 유산균의 인체 장내 안정성 분석> Human Intestinal Stability Analysis of Lactic Acid Bacteria>

(1)(One) 내산성Acid resistance ·· 내담즙성Bile resistance 평가 evaluation

가)end) 위산·담즙 재현을 위한 버퍼 제조 Buffer preparation for gastric and bile reproduction

위산과 담즙산에 의해 유산균이 장내로 도달하기 전 많은 수의 유산균이 사멸되는 점을 고려하여, 기능성 연구에 앞서 유산균의 장내 생존력을 관찰하고자 하였다. 장내 pH를 맞추기 위해 먼저, PBS 버퍼(1ℓ 기준, Sodium chloride 8g, Potassium chloride 0.2g, Sodium phosphate 1.44g, Potassium phosphate 0.24g, pH7.4)를 제조하여 오토클레이브(autoclave) 후, HCl을 첨가하여 위산 (pH 2.0~3.0) 환경을 만들고, 담즙염(bile salt)을 첨가하여 담즙산(0.3-0.4%) 환경을 만들어 하기 실험에 사용하였다.In view of the fact that a large number of lactic acid bacteria are killed before gastric acid and bile acids reach the intestine, the intestinal viability of lactic acid bacteria was examined prior to the functional studies. To adjust the intestinal pH, first, PBS buffer (based on 1 L, sodium chloride 8g, Potassium chloride 0.2g, Sodium phosphate 1.44g, Potassium phosphate 0.24g, pH7.4) was prepared and autoclave, and then HCl Gastric acid (pH 2.0 ~ 3.0) environment was made, bile salt (bile salt) was added to create a bile acid (0.3-0.4%) environment was used in the following experiment.

나)I) 내산성Acid resistance ·· 내담즙성Bile resistance 측정 Measure

본 실험에 앞서 균주를 2회 활성화(activation)하여 1.5㎖ 튜브에 1㎖를 담아 12,000 rpm, 4℃에서 5분간 원심 분리하였다. 상층액을 제거하여 균체를 회수한 후, 0.85% NaCl로 2회 세척하여 남아있는 배지를 제거하였다. pH 2.0과 3.0의 PBS 버퍼용액 및 0.3%와 0.4% 담즙염 용액을 각각 초기 배양액(1㎖)과 동량 첨가하여 재부유하였다. 음식물이 유입되어 위를 통과하는 시간이 2~4시간임을 고려하여 0, 90, 180분으로 반응시간을 설정해 시간별로 100㎕씩 샘플링하였다. 샘플링 용액(100㎕)은 900㎕의 버퍼로 pH를 회복한 뒤, 샘플로 사용하였다. 0.85% NaCl로 단계별로 희석하여 4등분 한 MRS 배지에 20㎕씩 스프레딩(spreading)하고, 24시간 후, 세포 계수(cell counting)하여 Log CFU/㎖값을 구하였다.Prior to this experiment, the strains were activated twice and placed in 1 ml in a 1.5 ml tube and centrifuged at 12,000 rpm and 4 ° C. for 5 minutes. The supernatant was removed to recover the cells, and then washed twice with 0.85% NaCl to remove the remaining medium. PBS buffer solutions at pH 2.0 and 3.0 and 0.3% and 0.4% bile salt solutions were resuspended in the same amount as the initial culture (1 ml), respectively. Considering that food is introduced and passing through the stomach is 2 to 4 hours, the reaction time was set to 0, 90, and 180 minutes, and sampled by 100 μl for each hour. The sampling solution (100 μl) was used as a sample after the pH was restored to 900 μl of buffer. Diluted with 0.85% NaCl step by step, spread 20µl each in quartered MRS medium, and after 24 hours, the cell count (cell counting) to obtain the Log CFU / ㎖ value.

락토바실러스 플란타룸 SPC-SNU 72-3 (Lb. plantarum SPC-SNU 72-3)을 각각 pH 2, 3 버퍼용액에 0, 90, 180분간 반응시킨 후 생균수를 측정한 결과, pH 2.0에서는 반응시간별 균수가 대폭 감소하는 경향을 보였다. 반면에, pH 3.0에서는 균수에 큰 변화가 없고, 90% 이상 생존력을 나타냈었다. 이러한 결과에 따라 락토바실러스 플란타룸 SPC-SNU 72-3은 대조구로 사용한 LGG(Lb. rhamnosus GG)균주보다 높은 생존율을 보여, 강한 산의 환경에서도 내성을 가짐을 확인할 수 있었다 (도 4). 도 4는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 pH에 따른 산 내성을 비교한 결과이다.The Lactobacillus plantarum SPC-SNU 72-3 ( Lb. plantarum SPC-SNU 72-3) was reacted with pH 2 and 3 buffer solutions for 0, 90 and 180 minutes, respectively. Bacterial counts by reaction time showed a significant decrease. On the other hand, at pH 3.0, there was no significant change in the number of bacteria, and the viability was over 90%. According to these results, Lactobacillus plantarum SPC-SNU 72-3 showed a higher survival rate than the LGG strain ( Lb. rhamnosus GG) strain used as a control, it was confirmed that the resistant even in a strong acid environment (Fig. 4). Figure 4 is a result of comparing the acid resistance according to the pH of the present invention Lactobacillus plantarum SPC-SNU 72-3.

한편, 락토바실러스 플란타룸 SPC-SNU 72-3을 각각 담즙염 0.3%, 0.4% 용액에 0, 90, 180분간 반응시킨 후 생균수를 측정한 결과, 두 농도의 담즙에서 모두 90분 반응시 균수가 감소하였으나, 그 후에 변화없이 유지되었다. 이러한 결과에 따라, 락토바실러스 플란타룸 SPC-SNU 72-3은 대조구로 사용한 LGG균주보다 높은 생존율을 보여 담즙의 환경에서도 내성을 가짐을 확인할 수 있었다 (도 5). 도 5는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 담즙 농도에 따른 유산균의 담즙내성을 비교한 결과이다.On the other hand, Lactobacillus plantarum SPC-SNU 72-3 was reacted with 0.3%, 0.4% solution of bile salts for 0, 90 and 180 minutes, respectively, and the number of viable cells was measured. The bacterial counts decreased, but then remained unchanged. According to these results, Lactobacillus plantarum SPC-SNU 72-3 showed a higher survival rate than the LGG strain used as a control it was confirmed that the resistance in the environment of bile (Fig. 5). 5 is a result of comparing the bile resistance of lactic acid bacteria according to the bile concentration of the present invention Lactobacillus plantarum SPC-SNU 72-3.

(2)(2) 장내 정착성Intestinal fixability

폴리스틸렌 막(polystylene membrane)은, 막 상에서 세포를 배양하면 자동적으로 분화하여 사람의 소장 상피세포와 형태학적, 생화학적으로 유사해짐으로써, 소장관 흡수 연구에 많이 이용되는 모델로, 인간 대장암에서 유래한 세포주인 Caco-2 세포를 사용하여 락토바실러스 플란타룸 SPC-SNU 72-3의 장관 내 부착능을 측정하였다 (도 6). 도 6은 대장 상피세포 Caco-2 세포를 이용해 장내 부착능을 평가한 결과이다. Polystylene membrane is a model widely used for small intestine absorption studies by morphologically and biochemically similar to human small intestinal epithelial cells when cells are cultured on the membrane. Intestinal adhesion of Lactobacillus plantarum SPC-SNU 72-3 was measured using one cell line, Caco-2 cells (FIG. 6). 6 is a result of evaluating intestinal adhesion capacity using colon epithelial cells Caco-2 cells.

대장 상피세포인 Caco-2 세포를 이용하여 장내 락토바실러스 플란타룸 SPC-SNU 72-3 균주의 정착능을 평가한 결과, 락토바실러스 플란타룸 SPC-SNU 72-3 균주가 Caco-2 100개의 세포 당 600개 이상의 균주가 부착되는 것을 관찰하였다. 결과적으로, 락토바실러스 플란타룸 SPC-SNU 72-3 균주는 대조군으로 사용한 LGG (Lb. rhamnosus GG)보다 3배가량 높은 수의 부착능을 보여 정착능이 우수한 것으로 확인되었다.As a result of evaluating the colonization ability of intestinal Lactobacillus plantarum SPC-SNU 72-3 strain using Caco-2 cells, which are colonic epithelial cells, 100 strains of Caco-2 Over 600 strains were observed per cell. As a result, the Lactobacillus plantarum SPC-SNU 72-3 strain showed a three times higher adhesion than LGG (Lb. rhamnosus GG) used as a control, it was confirmed that the fixing ability is excellent.

<< 실험예Experimental Example 3: 3: 건강기능성 분석>Health Functional Analysis>

(1)(One) Glucose를 제한한 플랜트 글리코사이드(Plant glycoside) 함유 배지에서 유산균의 β-글리코시데이즈 생산 유도Induction of β-glycosidase Production by Lactobacillus in Plant Glycoside Containing Plant Glycoside Containing Medium

가)end) 플랜트 글리코사이드 함유 배지에서 Lactobacillus plantarum SPC-SNU 72-3 균주의 생장 곡선 측정Measurement of Growth Curve of Lactobacillus plantarum SPC-SNU 72-3 Strains in Plant Glycoside Containing Medium

β-글리코시데이즈(beta-glucosidase) 생산을 유도하기 위해 락토바실러스 플란타룸 SPC-SNU 72-3 균주가 글루코오스 외에 대사할 수 있는 플랜트 글리코사이드인 아미그달린(amygdalin), 에스쿨린(Esculin), 살리신(Salicin), 알부틴(Arbutin)이 함유되어 있는 글루코오스 제한 배지에서 배양하여 생장곡선을 관찰하였다. 글루코오스를 제한한 배지에서 플랜트 글리코사이드의 농도는 아미그달린, 살리신, 알부틴은 각각 1%, 에스쿨린은 0.5%를 함유하게 제조하였다. 테스트는 96 마이크로 웰 플레이트에서 수행하였고 1개의 웰의 총 부피를 300㎕로 하여 24시간 동안 관찰하였으며, 2시간 마다 600nm에서 흡광도를 측정하였다 (도 7). 도 7은 글루코오스를 포함하지 않는 플랜트 글리코사이드(plant glycoside) 함유배지에서의 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 생장곡선을 나타낸 결과이다. Plant glycosides, amygdalin, esculin, and salicycin, which Lactobacillus plantarum SPC-SNU 72-3 strains can metabolize besides glucose to induce beta-glucosidase production (Salicin) and arbutin (Arbutin) cultured in glucose-restricted medium was observed growth curve. Plant glycoside concentrations in glucose-limited media were prepared to contain 1% for amigdaline, salicycin, and arbutin, and 0.5% for esculin. The test was carried out in 96 micro well plates and observed for 24 hours with the total volume of one well at 300 μl and the absorbance measured at 600 nm every 2 hours (FIG. 7). Figure 7 shows the growth curve of the present invention Lactobacillus plantarum SPC-SNU 72-3 in plant glycoside-containing medium that does not contain glucose.

실험 결과, 대조구인 글루코오스 배지에서 균의 성장속도가 빠르게 나타났으며, 살리신, 알부틴 배지에서는 10시간 이후, 에스쿨린 배지에서는 5시간 이후 정지기에 도달하였다. 한편, 아미그달린 배지에서는 가장 느리게 균이 성장하였다. 본 결과는 락토바실러스 플란타룸 SPC-SNU 72-3 균주가 글루코오스뿐만 아니라 식물체에 존재하는 다양한 배당체를 가수분해하여 탄소원으로 이용할 수 있음을 보여주는 것이다.As a result, the growth rate of the bacteria appeared in the control medium glucose medium, and reached the stop phase after 10 hours in salicycin, arbutin medium, and 5 hours in esculin medium. On the other hand, the fungus grew most slowly in the amidaline medium. This result shows that Lactobacillus plantarum SPC-SNU 72-3 strain can be used as a carbon source by hydrolyzing various glycosides present in plants as well as glucose.

나)I) Lactobacillus plantarum SPC-SNU 72-3 균주의 β-글리코시데이즈 효소 활성 측정 결과Β-Glycosidase Enzyme Activity Measurement Results of Lactobacillus plantarum SPC-SNU 72-3

플랜트 글리코사이드(배당체) 함유 배지에서 생장한 락토바실러스 플란타룸 SPC-SNU 72-3 균주를 8000 rpm, 10분간 원심분리하여 세포 펠렛을 준비한다. 수거된 세포 펠렛에 pH 7.0 소디움 포스페이드(sodium phosphate) 버퍼를 첨가한 후, 혼합하여 전체 세포 효소 분획 (whole cell enzyme fraction)을 준비였다. 96웰 플레이트에 pNP-G(para-nitrophenyl-α-D-glucopyranoside) 기질과 전체 세포 효소 분획을 함께 반응시켜 410nm에서 20분간의 흡광도 변화를 측정하여 β-글리코시데이즈 효소활성을 분석하였다 (도 8). 도 8은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3 균주의 효소 활성을 나타낸 그래프이다. 또한, 그 결과를 하기 표 2에 나타내었다. Cell pellets are prepared by centrifuging Lactobacillus plantarum SPC-SNU 72-3 strains grown in plant glycoside (glycoside) containing medium at 8000 rpm for 10 minutes. PH 7.0 sodium phosphate buffer was added to the collected cell pellets, followed by mixing to prepare a whole cell enzyme fraction. The β-glycosidase enzyme activity was analyzed by reacting the pNP-G (para-nitrophenyl-α-D-glucopyranoside) substrate and the whole cell enzyme fraction in a 96-well plate and measuring the change in absorbance at 410 nm for 20 minutes (FIG. 8). 8 is a graph showing the enzymatic activity of the Lactobacillus plantarum SPC-SNU 72-3 strain of the present invention. In addition, the results are shown in Table 2 below.

락토바실러스 플란타룸 SPC-SNU 72-3 균주의 β-글리코시데이즈 효소 활성(단위 : Unit/mL)Β-glycosidase enzyme activity of Lactobacillus plantarum SPC-SNU 72-3 strain (unit: mL) Carbon sourceCarbon source GlucoseGlucose ArbutinArbutin EsculinEsulin SalicinSalicin AmygdalinAmygdalin β-glucosidase activity of Lactobacillus plantarum SPC-SNU 72-3 β-glucosidase activity of Lactobacillus plantarum SPC-SNU 72-3
(units/mL)(units / mL)
0.0050.005 0.0660.066 0.0010.001 0.1100.110 0.2860.286

실험 결과, 락토바실러스 플란타룸 SPC-SNU 72-3 균주에서는 대조구인 글루코오스 함유 배지 대비 아미그달린 배지에서 효소활성이 약 57배, 살리신 배지에서 약 22배, 알부틴 배지에서 약 13배 증가하였다. 본 결과는 락토바실러스 플란타룸 SPC-SNU 72-3 균주가 배당체 기질이 존재할 때 β-글리코시데이즈 효소의 발현이 크게 유도됨을 보여준다.As a result, in the Lactobacillus plantarum SPC-SNU 72-3 strain, the enzyme activity was increased by about 57 times in the amidaline medium, about 22 times in the salysin medium, and about 13 times in the arbutin medium compared to the control medium containing glucose. The results show that Lactobacillus plantarum SPC-SNU 72-3 strains significantly induce the expression of β-glycosidase enzyme when glycoside substrates are present.

다)All) Lactobacillus plantarum SPC-SNU 72-3 균주의 β-글리코시데이즈의 진세노사이드 생물전환능Ginsenoside Bioconversion Capacity of β-Glycosidase of Lactobacillus plantarum SPC-SNU 72-3

플랜트 글리코사이드 함유 배지에서 생장한 락토바실러스 플란타룸 SPC-SNU 72-3 균주를 8000 rpm, 10분간 원심분리하여 세포 펠렛을 준비한다. 수거된 세포 펠렛에 pH 7.0 소디움 포스페이트(Sodium phosphate) 버퍼를 첨가한 후, 혼합하여 전체 세포 효소 분획(whole cell enzyme fraction)을 준비하였다. pH 7.0 소디움 포스페이트(Sodium phosphate) 버퍼에 0.3% 녹인 진세노사이드 Rb1과 전체 세포 효소 분획을 10 : 20의 비율로 혼합하여 30℃에서 72시간 반응시켰다. 전개용매는 클로로포롬 : 메탄올 : 물(65 : 35 : 10)을 혼합하여 그 하층액을 취하여 준비하고, TLC 판에 샘플링하여 전개시켰다. 이후, 10% 황산용액을 이용하여 120℃에서 10분간 발색하였다 (도 9). 도 9는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 베타-글리코시데이즈 효소에 의한 진세노사이드(Ginsenoside) Rb1 생물전환을 보여주는 TLC결과이다 (GM: ginsenoside mixtures, 1: Rb1 reacted with beta-glucosidase from Lb. plantarum SPC-SNU 72-3 cultured in glucose-MRS medium, 2: Rb1 reacted with beta-glucosidase from Lb. plantarum SPC-SNU 72-3 cultured in amygdalin-MRS medium).Cell pellets are prepared by centrifuging Lactobacillus plantarum SPC-SNU 72-3 strains grown in plant glycoside containing medium at 8000 rpm for 10 minutes. PH 7.0 sodium phosphate buffer was added to the collected cell pellets, followed by mixing to prepare a whole cell enzyme fraction. Ginsenoside Rb1 dissolved in 0.3% sodium phosphate buffer and total cell enzyme fraction were mixed at a ratio of 10:20 and reacted at 30 ° C for 72 hours. The developing solvent was prepared by mixing chloroform: methanol: water (65:35:10) by taking the lower layer solution, sampling it on a TLC plate, and developing it. Thereafter, using 10% sulfuric acid solution was developed for 10 minutes at 120 ℃ (Fig. 9). 9 is a TLC showing Ginsenoside Rb1 bioconversion by beta-glycosidase enzyme of the present invention Lactobacillus plantarum SPC-SNU 72-3 (GM: ginsenoside mixtures, 1: Rb1 reacted with beta-glucosidase from Lb.plantarum SPC-SNU 72-3 cultured in glucose-MRS medium, 2: Rb1 reacted with beta-glucosidase from Lb.plantarum SPC-SNU 72-3 cultured in amygdalin-MRS medium).

실험 결과, 대조구인 글루코오스를 함유한 MRS 배지에서 생장한 세포 펠렛을 이용하였을 때는 생물전환이 일어나지 않았지만, 글루코오스를 함유하지 않은 MRS 배지에 1%의 아미그달린(Amygdalin)을 첨가한 배지에서 얻은 세포 펠렛을 이용한 실험구에서는 진세노사이드 Rb1에서 진세노사이드 Rd로 생물전환이 이루진 것을 확인할 수 있었다.As a result of the experiment, cell pellets grown in MRS medium containing glucose did not undergo bioconversion, but cell pellets obtained from medium containing 1% Amygdalin added to MRS medium containing no glucose were added. In the experimental group used, it was confirmed that the bioconversion was made from ginsenoside Rb1 to ginsenoside Rd.

(2)(2) 장내감염 억제 Intestinal Infection Control

가)end) 항균활성 측정 Antimicrobial Activity

- 디스크 확산법(paper disc)Paper disc

헬리코박터 파이로리(Helicobacter pylori) 107 CFU/㎖를 접종한 평판배지를 제조한 후, 페이퍼 디스크를 얹어 각 4가지 프락션 (MRS : cell-free MRS broth, CFS : cell-free supernatant, concentrated 5 times, NS : neutralized supernatant (pH 7.0) by 5N NaOH, WC : washed cell)으로 나누어 락토바실러스 플란타룸 SPC-SNU 72-3 배양물을 로딩해 미호기성 환경에서 2~3일 배양한 뒤 저해환의 지름을 측정하였다. 한편, 락토바실러스 플란타룸 SPC-SNU 72-3 균주의 장내 유해균 (H. pylori, E. coli , L. monocytogenes , S. Typhimurium)에 대한 항균활성 결과를 하기 표 3에 나타내었다. Helicobacter pylori (Helicobacter pylori) 10 7 After preparing a plate medium inoculated CFU / ㎖, paper topped with a disc each of the four print raksyeon (MRS: cell-free MRS broth , CFS: cell-free supernatant, concentrated 5 times, NS: Neutralized supernatant (pH 7.0) by 5N NaOH, WC: washed cell) were loaded with Lactobacillus plantarum SPC-SNU 72-3 culture and cultured for 2 to 3 days in an aerobic environment. Measured. On the other hand, the antimicrobial activity against the intestinal harmful bacteria ( H. pylori, E. coli , L. monocytogenes , S. Typhimurium ) of Lactobacillus plantarum SPC-SNU 72-3 strain is shown in Table 3 below.

락토바실러스 플란타룸 SPC-SNU 72-3 균주의 장내 유해균에 대한 항균활성Antimicrobial Activity against Lactobacillus Plantarum SPC-SNU 72-3 Strains Diameter of inhibition zone (cm)Diameter of inhibition zone (cm) ControlControl MRSMRS WCWC CFSCFS Lactic acid conc. (mM)Lactic acid conc. (mM) NSNS EscherichiaEsherichia colicoli O157:H7O157: H7 1.05±0.051.05 ± 0.05 NDND NDND 0.95±0.050.95 ± 0.05 727.83727.83 NDND ListeriaListeria monocytogenesmonocytogenes 1.20±0.001.20 ± 0.00 NDND NDND 1.15±0.051.15 ± 0.05 727.83727.83 NDND Salmonella Salmonella TyphimuriumTyphimurium 1.30±0.001.30 ± 0.00 NDND NDND 0.95±0.050.95 ± 0.05 727.83727.83 NDND HelicobacterHelicobacter pylori  pylori 2.30±0.002.30 ± 0.00 NDND NDND 2.30±0.002.30 ± 0.00 727.83727.83 1.40±0.101.40 ± 0.10

*Ctl, Ampicillin, 0.1 %, 40 ㎕; MRS, cell-free MRS broth; WC, washed cell; CFS, cell-free supernatant, concentrated 5 times; NS, neutralized supernatant (pH 7.0) by 5N NaOH; WC, washed cell; ND, not detected* Ctl, Ampicillin, 0.1%, 40 μl; MRS, cell-free MRS broth; WC, washed cell; CFS, cell-free supernatant, concentrated 5 times; NS, neutralized supernatant (pH 7.0) by 5N NaOH; WC, washed cell; ND, not detected

4종의 장내 유해균 (H. pylori, E. coli , L. monocytogenes , S. Typhimurium)에 대한 항균 활성을 시험한 결과, 모든 상등액 (유산균이 생성한 lactic acid에 의해 pH )에서 저해를 보인 반면, 락토바실러스 플란타룸 72-3균주에서 pH를 보정해준 상등액에서 헬리코박터 파이로리의 생육을 저해하는 것으로 보여 박테리오신과 같은 항균성분의 존재를 알 수 있었다.Antimicrobial activity against four enteric harmful bacteria ( H. pylori, E. coli , L. monocytogenes , S. Typhimurium ) was tested and found to be inhibited in all supernatants (pH by lactic acid produced by lactic acid bacteria). In Lactobacillus plantarum 72-3 strains, the presence of antimicrobial compounds such as bacteriocin was observed in the supernatant with pH correction, which inhibited the growth of Helicobacter pylori.

- 응집력(Co- aggregation) 측정Co-aggregation measurement

107 CFU/㎖로 배양한 유산균과 유해균 4종(Esherichia coli , Listeria monocytogenes, Salmonella S. Typhimurium, Helicobacter pylori)을 co-aggregation 버퍼에 동량 첨가해 혼합하고, 10분 동안 반응한 후, 상층액의 흡광도를 측정하여 결과값을 산출하였고, 그 결과를 하기 표 4에 나타내었다.10 In a lactic acid bacteria and harmful bacteria in the culture CFU / 4 jong (Esherichia coli , Listeria monocytogenes , Salmonella S. Typhimurium and Helicobacter pylori ) were added to the co-aggregation buffer in the same amount, mixed and reacted for 10 minutes, and then the absorbance of the supernatant was measured to calculate the results, and the results are shown in Table 4 below. It was.

락토바실러스 플란타룸 SPC-SNU 72-3 균주에서의 응집력 백분율 비교Comparison of percentage cohesion in Lactobacillus plantarum SPC-SNU 72-3 strains  
 
Co-aggregation(Co-aggregation ( %% ) )
pH 3pH 3 pH 7pH 7 H. pyloriH. pylori E. E. colicoli L. L. monocytogenesmonocytogenes S. S. TyphimuriumTyphimurium Lb. Lb. plantarumplantarum SPC-SNU 72-3 SPC-SNU 72-3 39.4939.49 25.6725.67 45.5945.59 39.4939.49 Lb. Lb. brevisbrevis 14.3714.37 26.9326.93 23.0323.03 14.3714.37 Lb. Lb. curvatuscurvatus 16.5816.58 40.7740.77 33.633.6 16.5816.58 Lb. Lb. sanfranciscensissanfranciscensis 36.5436.54 27.1527.15 16.2216.22 36.5436.54

4종의 장내 유해균에 따른 항균 활성을 시험한 결과, 헬리코박터 파이로리(Helicobacter pylori)와 락토바실러스 플란타룸 SPC-SNU 72-3 균주에서 다른 균주와 비교하여 높은 응집력을 나타냈다. 또한, 락토바실러스 플란타룸 SPC-SNU 72-3 균주는 리스테리아 모노사이토제네스(L. monocytogenes), 살모넬라 타이피뮤리움(S. Typhimurium)과 공동 응집력이 40% 이상으로 나타났다. 결과적으로 락토바실러스 플란타룸 SPC-SNU 72-3 균주는 장내 유해균에 따라 대조구로 사용된 다른 유산균보다 높은 응집력을 보였으며, 이에 따라 응집력을 나타낸 균주에 대해 항균 활성을 가진다고 판단할 수 있다.After a test for antimicrobial activity according to the four types of intestinal harmful bacteria, from Helicobacter pylori (Helicobacter pylori) and Lactobacillus Planta room SNU SPC-72-3 strain as compared to other strains exhibited high cohesion. In addition, Lactobacillus Planta room SPC-72-3 SNU strain L. monocytogenes jeneseu (L. monocytogenes), S. typhimurium (S. Typhimurium) and the co-cohesion was greater than 40%. As a result, Lactobacillus plantarum SPC-SNU 72-3 strain showed a higher cohesive force than other lactic acid bacteria used as a control according to the intestinal harmful bacteria, and thus can be determined to have an antimicrobial activity against the strain showing the cohesive force.

(3)(3) 면역체계 강화 Immune system

가)end) 대식세포 분리 및 배양Macrophage Isolation and Culture

Balb/c 7주령 마우스 복강에 3.5% 타이오글리콜레이트 배지(Thioglycollate media; BD, Sparks, MD, USA) 2㎖를 주사하고 나서 4일 후에 마우스를 경추탈골한 후, 1% FBS(fetal bovine serum: Hyclone, Utah, USA), 1% 페니실린-스트렙토마이신(p/s)이 함유된 DMEM (Hyclone) 8㎖을 주입하여 대식세포를 수집하였다. 1000 rpm에 10분간 원심분리 후 대식세포를 DMEM 10% FBS, 1% p/s이 함유된 배지로 부유한 후, 세포수를 CountessⅡFL Automated Cell Counter (Life Technologies)를 이용하여 측정하였다. 실험에 필요한 대식세포는 37℃, 5% CO2조건의 인큐베이터에 overnight 배양하였다. 바닥에 붙지 않은 대식세포는 제거하고 각 균을 농도별로 24시간 동안 처리한 후 상등액의 배지를 회수하였다.Balb / c 7-week-old mouse intraperitoneally injected with 2 ml of 3.5% thioglycollate media (BD, Sparks, MD, USA) 4 days after the cervical distal bone, 1% FBS (fetal bovine serum) : Hyclone, Utah, USA), 8 ml of DMEM (Hyclone) containing 1% penicillin-streptomycin (p / s) was injected to collect macrophages. After centrifugation at 1000 rpm for 10 minutes, macrophages were suspended in a medium containing 10% FBS, 1% p / s of DMEM, and the number of cells was measured using a Countess IIFL Automated Cell Counter (Life Technologies). Macrophages required for the experiment was incubated overnight in an incubator at 37 ℃, 5% CO 2 conditions. Macrophages that did not adhere to the bottom were removed and each cell was treated for 24 hours by concentration, and then the supernatant was recovered.

나)I) 유산균 배양 및 사균체 제조Lactic Acid Bacteria Cultivation

유산균은 MRS broth 배지에 접종하여 최적온도인 30℃ 또는 37℃ 조건하에서 24시간 동안 shaking 배양하였다. 원심분리를 통해 상등액을 제거하고 0.85% NaCl로 2~3회 세척 후 pellet만을 모았다. 이를 항온수조(water bath)를 사용하여 100℃ 조건으로 5분간 열처리하여 사균화 한 후 동결건조를 진행하였다. 만들어진 동결건조체를 실험 농도별로 희석하여 시료로 사용하였다. Lactobacillus was inoculated in MRS broth medium and shaken for 24 hours under the optimum temperature of 30 ℃ or 37 ℃ conditions. The supernatant was removed by centrifugation and washed only 2-3 times with 0.85% NaCl to collect only pellets. This was quenched by heat treatment at 100 ° C. for 5 minutes using a water bath and then lyophilized. The lyophilisate produced was diluted by experimental concentration and used as a sample.

다)All) 사이토카인 측정Cytokine measurement

사이토카인 함량은 enzyme-linked immunosorbent assay(ELISA) 방법을 이용하여 측정하였다. TNF-α, IL-6 Duoset (R&D Systems, USA), 1L-12 OptEIA set(BD, USA)을 사용하였으며 제조사의 프로토콜을 따라 ELISA를 수행하였다.Cytokine content was measured using an enzyme-linked immunosorbent assay (ELISA) method. TNF-α, IL-6 Duoset (R & D Systems, USA) and 1L-12 OptEIA set (BD, USA) were used and ELISA was performed according to the manufacturer's protocol.

TNFTNF -α, IL-6 -α, IL-6 DuosetDuoset (R&D Systems, USA) (R & D Systems, USA)

96웰 이뮤노플레이트(immunoplate)에 각각의 포획 항체(capture antibody)를 PBS에 희석하여 0.1㎖씩 분주한 후, 상온에서 overnight 반응하였다. 세척버퍼 (0.5% Tween/PBS)로 각 웰을 3번 세척한 후, 블록킹 버퍼 (blocking buffer; 1% BSA in PBS) 0.3㎖를 각 웰에 넣고 1시간 동안 반응하였다. 이후, 각 웰을 세척 버퍼로 3번 세척하고, 스탠다드(standard)와 샘플(sample)을 희석하여 0.1㎖씩 분주한 후에 2시간 동안 반응시켰다. 그 후, 세척 버퍼로 각 웰을 세척한 후 블록킹 버퍼에 바이오틴(biotin)이 결합된 2차 항체를 희석하여 각 웰 당 0.1㎖씩 분주하고 2시간 동안 상온에서 반응하였다. 이후, 세척 버퍼로 웰을 3번 세척한 후, 블록킹 버퍼에 Streptavidin-HRP 용액을 희석하여 0.1㎖씩 분주하고, 상온에서 20분간 반응시켰다. 그 후, 각 웰을 세척 버퍼로 세척한 후, TMB(BD pharmingen) 용액을 웰당 0.1㎖씩 처리한 뒤, 상온에서 30분간 반응시키고, 2N H2SO4 용액을 0.05㎖씩 각 웰에 첨가하여 완료하였다. 96웰 microplate reader를 사용하여 450nm에서 흡광도를 측정하였다. Each capture antibody was diluted in PBS and dispensed by 0.1 ml in 96-well immunoplate, and then reacted overnight at room temperature. After washing each well three times with a washing buffer (0.5% Tween / PBS), 0.3 ml of blocking buffer (1% BSA in PBS) was added to each well and reacted for 1 hour. Thereafter, each well was washed three times with a wash buffer, and the standard and the sample were diluted and dispensed 0.1 ml each, followed by reaction for 2 hours. Thereafter, each well was washed with a washing buffer, followed by diluting a secondary antibody conjugated with biotin in a blocking buffer, dispensing 0.1 ml of each well, and reacting at room temperature for 2 hours. Thereafter, the wells were washed three times with a washing buffer, and then diluted 0.1 ml of the Streptavidin-HRP solution in the blocking buffer, followed by reaction at room temperature for 20 minutes. Thereafter, each well was washed with a washing buffer, and then treated with 0.1 ml of TMB (BD pharmingen) solution per well, followed by reaction at room temperature for 30 minutes, and 2N H 2 SO 4 solution was added to each well by 0.05 ml. Completed. Absorbance was measured at 450 nm using a 96 well microplate reader.

② IL-12 ② IL-12 OptEIAOptEIA set ( set ( BDBD , USA), USA)

96웰 이뮤노플레이드(immunoplate)에 각각의 포획 항체(capture antibody)를 PBS에 희석하여 0.1㎖씩 분주한 후, 냉장에서 overnight 반응하였다. 세척 버퍼 (0.5% Tween/PBS)로 각 웰을 3번 세척한 후 블록킹 버퍼(10% FBS, Welgene, Korea) 0.2㎖를 각 웰에 넣고 1시간 동안 반응하였다. 각 웰을 세척 버퍼로 3번 세척하고, 스탠다드(standard)와 샘플(sample)을 희석하여 0.1㎖씩 분주한 후 2시간 반응시켰다. 세척 버퍼로 각 웰을 세척한 후 블록킹 버퍼에 바이오틴(biotin)이 결합된 2차 항체와 Streptavidin-HRP 용액을 희석하여 0.1㎖씩 분주하고, 상온에서 1시간 동안 반응시켰다. 각 웰을 세척 버퍼로 세척한 TMB(BD pharmingen) 용액을 웰당 0.1㎖씩 처리한 후, 상온에서 30분간 반응시키고 2N H2SO4 용액을 0.05㎖씩 각 웰에 첨가하여 반응을 완료하였다. 96 well microplate reader를 사용하여 450nm에서 흡광도를 측정하였다.Each capture antibody was diluted in PBS and dispensed by 0.1 ml in 96-well immunoplate, and then reacted overnight in refrigeration. After washing each well three times with washing buffer (0.5% Tween / PBS), 0.2 ml of blocking buffer (10% FBS, Welgene, Korea) was added to each well and reacted for 1 hour. Each well was washed three times with a wash buffer, and the standard and samples were diluted and dispensed by 0.1 ml, followed by reaction for 2 hours. After washing each well with a washing buffer, diluting the biotin-bound secondary antibody and Streptavidin-HRP solution in the blocking buffer and dispensing 0.1 ml each, and reacting for 1 hour at room temperature. Each well was treated with 0.1 ml / well TMB (BD pharmingen) solution washed with washing buffer, and then reacted at room temperature for 30 minutes, and 2N H 2 SO 4 solution was added to each well by 0.05 ml to complete the reaction. Absorbance was measured at 450 nm using a 96 well microplate reader.

샘플이 면역세포의 일종인 대식세포의 PAMP(pathogen-associated molecular pattern)를 자극하여 면역 관련 사이토카인의 분비를 유도하는지 확인한 결과, 락토바실러스 플란타룸 SPC-SNU 72-3균주의 TNF-α, IL-6의 분비는 균의 농도에 따라 증가하는 경향이 나타났으나, IL-12는 다른 사이토카인과 달리 최고 농도인 100㎍/㎖보다 4-20㎍/㎖의 균을 처리하였을 때, 유도능이 더욱 높게 나타나는 경향을 보였다. 결과적으로 체외(in vitro) 조건에서 세 가지의 사이토카인 (TNF-α, IL-6, IL-12) 유도능 측정 결과, 락토바실러스 플란타룸 SPC-SNU 72-3은 대조구로 사용한 LGG보다 높은 사이토카인 유도능이 확인되어 면역조절 활성을 낼 것으로 판단된다. 이를 하기 표 5 내지 7에 나타내었다.As a result of confirming that the sample stimulates the pathogen-associated molecular pattern (PAMP) of macrophages, which are a kind of immune cells, to induce the secretion of immune-related cytokines, TNF-α of Lactobacillus plantarum SPC-SNU 72-3 strain, The secretion of IL-6 tended to increase with the concentration of bacteria, but unlike other cytokines, IL-12 was induced when 4-20 µg / ml bacteria were treated than the highest concentration of 100 µg / ml. The ability tended to be higher. As a result, three cytokine (TNF-α, IL-6, IL-12) inducing ability measurement in vitro conditions, Lactobacillus plantarum SPC-SNU 72-3 was higher than the control LGG Cytokine induction ability has been confirmed, and is expected to have immunomodulatory activity. This is shown in Tables 5 to 7 below.

TNFTNF -α (농도, -α (concentration, pgpg /ml)/ ml) (( pgpg /ml)/ ml) 4 4 ugug /ml/ ml 20 20 ugug /ml/ ml 100 100 ugug /ml/ ml L. L. rhamnosusrhamnosus GGGG 0.00 ±0.00 0.00 ± 0.00 807.33 ±856.71 807.33 ± 856.71 6330.67 ±1641.65 6330.67 ± 1641.65 L. L. plantarumplantarum SPC-SNU 72-3 SPC-SNU 72-3 16449.00±4487.0016449.00 ± 4487.00 19190.83±685.1519190.83 ± 685.15 16982.50±4634.2616982.50 ± 4634.26

IL-6 (농도, IL-6 (concentration, pgpg /ml)/ ml) (( pgpg /ml)/ ml) 4 4 ugug /ml/ ml 20 20 ugug /ml/ ml 100 100 ugug /ml/ ml L. L. rhamnosusrhamnosus GGGG 30.83 ±51.26 30.83 ± 51.26 13.33 ±23.09 13.33 ± 23.09 485.83 ±104.83 485.83 ± 104.83 L. L. plantarumplantarum SPC-SNU 72-3 SPC-SNU 72-3 3295.00±2633.493295.00 ± 2633.49 5118.61±2951.515118.61 ± 2951.51 3151.94±1400.053151.94 ± 1400.05

IL-12 (농도, IL-12 (concentration, pgpg /ml)/ ml) (( pgpg /ml)/ ml) 4 4 ugug /ml/ ml 20 20 ugug /ml/ ml 100 100 ugug /ml/ ml L. L. rhamnosusrhamnosus GGGG 17.00±29.44 17.00 ± 29.44 25.44±44.07 25.44 ± 44.07 109.44±62.21 109.44 ± 62.21 L. L. plantarumplantarum SPC-SNU 72-3 SPC-SNU 72-3 3536.33±2550.693536.33 ± 2550.69 2590.5±1801.882590.5 ± 1801.88 338±307.60338 ± 307.60

<< 실험예Experimental Example 4: 제빵적성 평가> 4: Bakery Aptitude Evaluation>

(1)(One) 락토바실러스Lactobacillus 플란타룸의Plantarum 말토오스  maltose 이용능Utilization 확인 Confirm

가)end) 생장곡선(growth curve)Growth curve

하기 표 8과 같은 조성을 가지는 2% 말토오스 함유 MRS 배지(broth medium)를 만든 후 72-3 분리균주, 공시균주(KACC11451), 상업균주(Lallemand L73)를 각각 10%(w/v)씩 접종하고 10시간 배양한 후, 600nm에서 흡광도를 측정하여 생장 곡선(growth curve)을 작성하였다 (도 10). 도 10은 말토오스 배지에서 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 배양학적 특성을 나타낸 결과이다. 실험 결과, 72-3 분리균주가 상업균주보다 말토오스(maltose) 배지에서의 생육 속도가 빠름을 확인할 수 있었다.To make a 2% maltose-containing MRS medium (broth medium) having the composition shown in Table 8, and then inoculated by 10% (w / v) 72-3 isolate, public strain (KACC11451), commercial strain (Lallemand L73), respectively After incubation for 10 hours, the absorbance was measured at 600 nm to generate a growth curve (FIG. 10). 10 is a result showing the culture characteristics of the present invention Lactobacillus plantarum SPC-SNU 72-3 in maltose medium. As a result, 72-3 isolates were found to grow faster in maltose medium than commercial strains.

2% 말토오스 함유 MRS 배지(broth medium)MRS broth medium containing 2% maltose 조성Furtherance 함량content 프로테오스 펩톤Proteos peptone 10.0g10.0 g 비프 추출물Beef extract 10.0g10.0 g 이스트 추출물Yeast extract 5.0g5.0 g 말토오스maltose 20.0g20.0 g 소디움 아세테이트Sodium acetate 5.0g5.0 g 디포타슘 포스페이트Dipotassium Phosphate 2.0g2.0 g 시트르산 암모늄Ammonium citrate 2.0g2.0 g 폴리소르베이트 80Polysorbate 80 1.0g1.0 g 마그네슘 설페이트Magnesium sulfate 0.1g0.1g 망가니즈 설페이트Manganese Sulfate 0.05g0.05g 증류수Distilled water 1L1L

나)I) 잔당분석(maltose)Maltose Analysis

말토오스 함유 MRS 배지에 72-3 분리균주, 공시균주(KACC11451), 상업균주(Lallemand L73)를 각각 10%씩 접종하고 10시간 배양한 후, 2시간 간격으로 시료를 채취하여 상등액을 잔당(maltose)분석에 이용하였다. 당분석은 HPLC(SHISEIDO NANOSPACE S1-2)를 이용하여 수행하였다. HPLC 조건으로는 이동상은 80% ACN을 유속 1㎖/min으로 흘려주었고, 35℃로 가열된 당분석용 컬럼(Waters carbohydrate High performance 4㎛)과 RI detector를 이용하였다 (도 11). 도 11은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3의 말토오스 이용능을 확인한 결과이다. 실험 결과, 72-3 분리균주가 공시균주 및 상업균주보다 말토오스 이용능이 우수함을 확인할 수 있었다.Inoculated with 72-3 isolates, test strains (KACC11451) and commercial strains (Lallemand L73) in maltose-containing MRS medium at 10% each and incubated for 10 hours. Used for analysis. Sugar analysis was performed using HPLC (SHISEIDO NANOSPACE S1-2). In HPLC conditions, the mobile phase was allowed to flow 80% ACN at a flow rate of 1 ml / min, and a sugar analysis column heated at 35 ° C. (Waters carbohydrate High performance 4 μm) and RI detector were used (FIG. 11). 11 is a result confirming the maltose capacity of the present invention Lactobacillus plantarum SPC-SNU 72-3. As a result, it was confirmed that 72-3 isolates had better maltose capacity than test strains and commercial strains.

(2)(2) 락토바실러스Lactobacillus 플란타룸Planta Room (Lactobacillus (Lactobacillus plantarumplantarum )의 제빵적용 Baking application of

본 실험에서는 김치에서 분리한 락토바실러스 플란타룸과 공시균주(KACC11451), 상업균주(Lallemand L73)를 각각 제빵에 적용하고, 그 특성을 확인하고자 하였다.In this experiment, Lactobacillus plantarum, test strain (KACC11451), and commercial strain (Lallemand L73) isolated from kimchi were applied to baking, and their characteristics were examined.

가)end) 유산균 발효 반죽의 제조 및 분석Preparation and Analysis of Lactic Acid Bacteria Fermented Dough

강력분 100g, 유산균수 2x1010 cfu/g, 가열냉각수 100g을 혼합한 후, 30℃의 발효기에서 발효시켜 유산균 발효 반죽을 제조하되, 반죽의 pH가 pH 4.0±0.2에 도달하였을 때, 냉각한 후 유산균 발효 반죽의 pH, TTA 및 균수를 측정하였다. 한편, 본 실험에서 사용한 유산균은 MRS 배지에서 30℃, 22±2시간 동안 배양한 후, 원심분리하여 균체회수 후, 균체를 생리식염수로 수회 세척 후 이용하였고, 최초 균 접종량은 반죽 1g당 1×108이 될 수 있도록 접종하였다.Lactic acid bacteria 100g, lactic acid bacteria number 2x10 10 cfu / g, heated cooling water 100g mixed and fermented in a fermenter at 30 ℃ to prepare a lactic acid bacteria fermented dough, when the pH of the dough reaches pH 4.0 ± 0.2, after cooling the lactic acid bacteria The pH, TTA and bacterial count of the fermented dough were measured. On the other hand, the lactic acid bacteria used in this experiment was incubated in MRS medium for 30 ℃, 22 ± 2 hours, centrifuged and recovered the cells, the cells were washed with physiological saline several times, the first inoculation amount was 1 × 1g per dough Inoculated to be 10 8 .

실험 결과는 하기 표 9에 나타내었다. 실험 결과, 분리균주, 공시균주를 적용한 반죽 모두 pH 4.0±0.2 도달까지 4시간이 소요됐으며, 냉각 후 균수 분석 결과 또한 비슷한 것으로 나타났다.The experimental results are shown in Table 9 below. As a result, it took 4 hours to reach pH 4.0 ± 0.2 for both the strains and the pastes applied with the strains.

반죽의 pH가 pH 4.0±0.2에 도달하였을 때, 냉각한 후 유산균 발효 반죽의 pH, TTA 및 균수 측정When the pH of the dough reaches pH 4.0 ± 0.2, measure the pH, TTA and number of bacteria of lactic acid bacteria fermented dough after cooling pHpH TTA (TTA ( 15 g15 g 기준, ml) Standard, ml) 균수Bacteria ( ( cfucfu /g)/ g) 유기산Organic acid pH 6.6pH 6.6 pH 8.5pH 8.5 SPC-SNU 72-3
(Lb. plantarum KCTC13316BP)
적용 반죽
SPC-SNU 72-3
( Lb. plantarum KCTC13316BP)
Apply dough
3.863.86 9.219.21 11.6811.68 1.21x109 1.21 x 10 9 Lactic acid 0.46%
Acetic acid 0.052%
Lactic acid 0.46%
Acetic acid 0.052%
상업균주(Lb. plantarum Lallemand L73)
적용 반죽
Commercial strain (Lb. plantarum Lallemand l73)
Apply dough
3.883.88 8.758.75 11.1411.14 1.38x109 1.38 x 10 9 Lactic acid 0.35%
Acetic acid 0.051%
Lactic acid 0.35%
Acetic acid 0.051%
공시균주(Lb. plantarum KACC 11451)
적용 반죽
Test strain (Lb. plantarum KACC 11451)
Apply dough
3.843.84 9.359.35 11.7011.70 1.54x109 1.54 x 10 9 Lactic acid 0.76%
Acetic acid 0.076%
Lactic acid 0.76%
Acetic acid 0.076%

나)I) 빵 제조Bread manufacturing

식빵 제조방법은 스펀지(Sponge)법에 의해 진행되었다.Bread manufacturing method was carried out by the sponge (Sponge) method.

배합공정(중종) 및 1차 발효Compounding process (medium seed) and primary fermentation

하기 표 10에 제시한 바와 같은 성분을 믹서(제품명: SK101S MIXER : 일본)에 투입하고, 2단에서 2분, 3단에서 1분 동안 반죽하고, 반죽의 최종온도가 25℃가 되도록 혼합한 후, 27℃ 발효기에 넣어 4시간 동안 1차 발효시켰다.To the ingredients as shown in Table 10 below into a mixer (product name: SK101S MIXER: Japan), kneading for 2 minutes in 2 stages, 1 minute in 3 stages, and mixed so that the final temperature of the dough is 25 ℃ Into the fermentor, 27 ℃ primary fermentation for 4 hours.

대조구(상업적 이스트만 적용된 빵)Control (bread with commercial yeast only) Lb.Lb. plantarumplantarum SPC-SNU 72-3 SPC-SNU 72-3
(( KCTC13314BKCTC13314B ))
적용 빵Applied bread
상업균주Commercial strain
Lb. Lb. plantarumplantarum Lallemand L73Lallemand l73
적용 빵Applied bread
공시균주Disclosure strain
Lb. Lb. plantarumplantarum
(( KACCKACC 11451) 11451)
적용 빵Applied bread
중종Zhongjong 밀가루flour 7070 7070 7070 7070 Sac. cerevisiae
SPC 70-1
Sac. cerevisiae
SPC 70-1
22 22 22 22
급수rating 4242 4242 4242 4242 본종Main species 밀가루flour 3030 2020 2020 2020 정제염Refined salt 22 22 22 22 정백당White sugar 44 44 44 44 탈지분유Skim milk powder 44 44 44 44 유지maintain 1212 1212 1212 1212 급수rating 2323 1313 1313 1313 유산균
발효종
Lactobacillus
Fermented species
-- 2020 2020 2020

배합공정(Compounding process ( 본종Main species ) 및 2차 발효) And secondary fermentation

상기 표 10에 제시한 바와 같은 성분으로 1차 발효된 반죽물과 밀가루, 정백당, 정제염, 전지분유, 이스트, 정제수를 믹서에 투입하여 1단에서 1분간 반죽하고 상기 중종 공정에서 제조된 발효물을 넣고 2단에서 3분 3단에서 2분간 혼합하였다. 다음으로, 버터를 첨가하고 2단에서 3분, 3단에서 3분간 반죽하여, 반죽 조성물의 최종 온도가 27℃가 되도록 하였다. 반죽을 성형한 이후 팬닝한 다음 38℃, 상대습도 85%에서 100분간 2차 발효를 하였다.The first fermented dough and flour, white sugar, refined salt, whole milk powder, yeast, purified water with the ingredients as shown in Table 10, kneaded in the first stage for 1 minute and the fermented product prepared in the middle seed process The mixture was mixed in two stages for 3 minutes and 3 stages for 2 minutes. Next, butter was added and kneaded in two stages for three minutes and three stages for three minutes, so that the final temperature of the dough composition was 27 ° C. After molding, the pan was panned and then subjected to secondary fermentation for 100 minutes at 38 ° C. and a relative humidity of 85%.

소성 및 냉각공정Firing and Cooling Process

2차 발효공정을 거친 반죽을 윗불 210℃, 아랫불 250℃의 테크오븐에 37분간 구운 후, 빵틀에서 꺼내어 실온에서 내부온도가 32℃로 될 때까지 냉각하였다 (도 12). 도 12는 공시균주로 사용한 락토바실러스 플란타룸 KACC11451가 적용된 빵, 락토바실러스 플란타룸의 상업균주인 Lallemand L73이 적용된 빵, 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3이 적용된 빵의 사진이다.The dough, which was subjected to the secondary fermentation process, was baked in an upper oven at 210 ° C. and a lower oven at 250 ° C. for 37 minutes. 12 is a bread to which the Lactobacillus plantarum KACC11451 is applied as a test strain, a bread to which Lallemand L73, a commercial strain of Lactobacillus plantarum, is applied, and a bread to which the present invention Lactobacillus plantarum SPC-SNU 72-3 is applied. to be.

(3)(3) 관능 평가 및 빵의 물성 측정Sensory evaluation and measurement of bread properties

가)end) 빵의 물성 측정Measurement of the physical properties of bread

대조구(상업적 이스트만 적용된 빵), 분리균주가 적용된 빵, 상업균주(Lallemand L73)가 적용된 빵, 공시균주(Lb. plantarum KACC11451)가 적용된 빵의 물성(pH, 총 적정산도, 색도)을 측정하고자 하였다. pH 측정은 250㎖ 비이커에 증류수 100㎖, 시료 15g을 넣고 균질화한 후, pH 미터(pH meter)로 측정하였다. 총적정 산도(total titrable acid; TTA)는 0.1 N NaOH 용액으로 적정하여 pH 6.6과 pH 8.5에 이를 때까지의 NaOH 용액 소비량(㎖)으로 정의하였다. 색도 측정은 빵을 약 20㎜ 두께로 잘라낸 시료를 색도계 (CR-400, KONIKA MINOLTA사)를 이용하여 측정하였고, 그 결과를 하기 표 11에 나타내었다. 실험 결과, 대조구와 유산균 첨가구의 빵의 물성은 전반적으로 유사한 것을 확인할 수 있었다.We tried to measure the physical properties (pH, total titratable acidity, chromaticity) of control (bread with commercial yeast only), bread with separate strain, bread with commercial strain (Lallemand L73), and bread with public strain (Lb. plantarum KACC11451). . The pH was measured by homogenizing 100 ml of distilled water and 15 g of a sample in a 250 ml beaker, followed by homogenization. Total titrable acid (TTA) was defined as the amount of NaOH solution consumed (ml) until titrated with 0.1 N NaOH solution to pH 6.6 and pH 8.5. Color measurement was measured using a colorimeter (CR-400, KONIKA MINOLTA Co., Ltd.) of the bread cut to a thickness of about 20 mm, the results are shown in Table 11 below. As a result, the physical properties of the bread of the control and the addition of lactic acid bacteria were confirmed to be generally similar.

빵의 물성 측정Measurement of the physical properties of bread 항목Item 적용 제품 관능평가 및 제품 특성Applied Product Sensory Evaluation and Product Characteristics ControlControl Lb.Lb. plantarumplantarum
SPC-SNU 72-3SPC-SNU 72-3
적용 빵Applied bread
상업적균주Lb.plantarumCommercial strain Lb.plantarum LallemandLallemand L73 L73
적용 빵Applied bread
공시균주Disclosure strain
Lb.Lb. plantarumplantarum (KACC11451) (KACC11451)
적용 빵Applied bread
비용적Cost 4.884.88 4.904.90 4.854.85 4.874.87 *식감Texture 7.47.4 7.97.9 7.87.8 7.77.7 *풍미*zest 7.37.3 7.57.5 7.67.6 7.67.6 pHpH 5.535.53 5.305.30 5.355.35 5.295.29 TTA(6.6/8.5)TTA (6.6 / 8.5) 2.27/4.872.27 / 4.87 3.27/5.313.27 / 5.31 3.29/5.183.29 / 5.18 3.25/5.273.25 / 5.27 수분함량(%)Moisture content (%) 41.65 %41.65% 41.58%41.58% 41.49%41.49% 41.54%41.54% 유기산Organic acid Lactic acid 0.015%
Acetic acid 0.037%
Lactic acid 0.015%
Acetic acid 0.037%
Lactic acid 0.152%
Acetic acid 0.048%
Lactic acid 0.152%
Acetic acid 0.048%
Lactic acid 0.152%
Acetic acid 0.043%
Lactic acid 0.152%
Acetic acid 0.043%
Lactic acid 0.154%
Acetic acid 0.040%
Lactic acid 0.154%
Acetic acid 0.040%
LL 84.1184.11 84.9284.92 85.0185.01 84.9184.91 Hunter labHunter lab
color valuescolor values
aa -2.16-2.16 -2.15-2.15 -2.11-2.11 -2.19-2.19
bb 17.7217.72 17.3317.33 17.3217.32 17.5117.51

* 1:매우 나쁨, 9:매우 우수* 1: Very bad, 9: Very good

나)I) 반죽의 가스 Gas of dough 발생력Generating force 확인 Confirm

대조구(상업적 이스트만 적용된 본종), 상업균주(Lallemand L73)가 적용된 본종, 공시균주(KACC11451)가 적용된 본종, 분리균주가 적용된 본종의 가스 발생력을 비교하고자 하였다. 가스발생력 측정은 배합공정(본종)의 반죽조성물을 25g을 취하여 가스발생력측정기(Fermometer)를 통해 30℃ 온도조건에서 10시간의 측정값을 기재하였다 (도 13). 도 13은 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3, 상업균주인 Lallemand L73, 공시균주로 사용한 락토바실러스 플란타룸 KACC11451가 각각 적용된 본종의 가스 발생력을 확인한 결과이다. 실험 결과, 대조구와 유산균 첨가구의 가스발생력은 전반적으로 유사하나 유산균 첨가구의 초기 가스발생력이 다소 높음을 확인할 수 있었다.This study was designed to compare the gas generating powers of the control group (primary strains with commercial yeast), the strains with commercial strain (Lallemand L73), the strains with strain (KACC11451), and the strains with separate strain. Gas generation force measurement was 25g of the dough composition of the blending process (main species) and described the measured value of 10 hours at 30 ℃ temperature conditions through a gas generator (Fermometer) (Fig. 13). 13 is a result of confirming the gas generating power of the present species to which the present invention Lactobacillus plantarum SPC-SNU 72-3, a commercial strain Lallemand L73, a lactobacillus plantarum KACC11451 used as a test strain. As a result, the gas generating powers of the control and the addition of lactic acid bacteria were generally similar, but the initial gas generating power of the lactic acid bacteria added group was found to be rather high.

다)All) 빵의 노화도 측정Determination of Aging in Bread

상기와 같이 제조된 빵 중 실험구와 대조구의 시간 변화에 따른 노화 속도를 측정하고자, 빵을 상온에서 3시간 동안 식힌 후 약 20mm 두께로 잘라낸 시료의 노화도(hardness)를 물성측정기(Texture analyser, Stable Micro Systems사)를 이용하여 측정하였으며, 경도에 대한 값은 하기 표 12에 나타내었다 (도 14). 도 14는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3이 적용된 빵의 노화 속도를 측정한 결과이다. 제품 보관에 따른 경도(Hardness) 비교 결과, 유산균을 사용한 경우 전반적으로 경도가 적어 부드러움이 우수한 것을 알 수가 있었으며, 전반적으로 대조구보다 노화속도는 느린 것을 확인할 수 있었다.In order to measure the aging rate according to the time change of the test and control of the bread prepared as described above, the hardness of the sample cut to about 20mm thickness after cooling the bread for 3 hours at room temperature (Texture analyser, Stable Micro Systems), and the values for hardness are shown in Table 12 below (FIG. 14). 14 is a result of measuring the aging rate of the bread to which the present invention Lactobacillus plantarum SPC-SNU 72-3 is applied. As a result of the hardness (Hardness) comparison according to the product storage, when the lactic acid bacteria were used, the overall hardness was low and the softness was excellent, and the overall aging rate was slower than the control.

빵의 경도 측정Hardness measurement of bread SampleSample Hardness(N)Hardness (N) 19시간경과19 hours 63시간경과63 hours 87시간경과87 hours ControlControl 1.6521.652 2.6152.615 2.6802.680 Lb. plantarum SPC-SNU 72-3 발효종적용 Lb. plantarum SPC-SNU 72-3 1.5341.534 2.4922.492 2.5122.512 Lb. plantarum L73 발효종적용 Lb. plantarum L73 fermented seed 1.5321.532 2.5092.509 2.5302.530 Lb. plantarum(KACC 11451)
발효종적용
Lb. plantarum (KACC 11451)
Fermented seed application
1.5161.516 2.5572.557 2.5832.583

라)la) 유산균주Lactobacillus 적용 반죽 향기 성분 분석 Application dough fragrance ingredient analysis

대조구 대비 유산균 발효반죽을 이용한 제빵의 제조 시, 풍미 성분 발현을 비교하기 위하여, GC/MS 시스템을 이용하여 분석하였다. 시료 1g에 관한 분석을 수행하였고, GC/MS 분석 조건은 하기 표 13과 같았다. GC/MS 분석 후, 알코올(alcohol), 알데하이드(aldehyde), 케톤(ketone), 산(acid)류에 대한 전체적인 정량적 수치를 비교하고 (도 15), 하기 표 14에 대표적 향기 성분 19종에 대하여 각 성분의 상대적 비율을 백분율로 나타내었다. 도 15는 본 발명 락토바실러스 플란타룸 SPC-SNU 72-3이 적용된 빵 (시료) 1g당 검출된 휘발성 향기성분 (alcohol, aldehyde, ketone, acid 류 등)의 전체적인 정량적 수치를 비교한 결과이다.In the manufacture of bakery using lactic acid bacteria fermented dough compared to the control, in order to compare the expression of flavor components, it was analyzed using GC / MS system. An analysis was performed on 1 g of samples, and GC / MS analysis conditions were as shown in Table 13 below. After GC / MS analysis, the overall quantitative values for alcohols, aldehydes, ketones, and acids were compared (FIG. 15), and in Table 14, for the 19 representative fragrance components, The relative proportions of each component are expressed as percentages. FIG. 15 is a result of comparing the quantitative values of volatile aroma components (alcohol, aldehyde, ketone, acid, etc.) detected per 1g of bread (sample) to which the present invention Lactobacillus plantarum SPC-SNU 72-3 is applied.

실험 결과, Lallemand L73 대비 실험구에서 향기성분 함량 높게 나타났고, 분리균주는 알코올과 케톤류 함량이 높았다. 또한, Lallemand L73는 풋내를 일으키는 헥사날(hexanal)의 함량이 높았고, 부드러운 풍미를 나타내는 아세토인(acetoin)의 함량은 72-3 분리균주에서 높게 나타났다.As a result, the content of aroma component was higher in the experimental group compared to Lallemand L73, and the isolates were higher in alcohol and ketones . In addition, Lallemand L73 had a high content of hexanal, which causes greening, and acetoin (acetoin) showing a soft flavor was high in 72-3 isolates.

GC/MS 분석 조건GC / MS Analysis Conditions 분석시스템Analysis system 운영 조건Operating conditions GC/MS analysisGC / MS analysis GC Model name : Agilent 7890A
Inlet temperature : 230℃
Column : DB-WAX (60 m X 250 um X 0.25 uM)
Carrier gas : helium
Flow rate : 1 ㎖/min
Oven temperature program : from 40℃ (5 min) → 8℃/min → 230℃ (10min)
MS detector : Agilent 5975C MSD (EI mode)
GC Model name: Agilent 7890A
Inlet temperature: 230 ℃
Column: DB-WAX (60 m X 250 um X 0.25 uM)
Carrier gas: helium
Flow rate: 1 ml / min
Oven temperature program: from 40 ℃ (5 min) → 8 ℃ / min → 230 ℃ (10min)
MS detector: Agilent 5975C MSD (EI mode)
SPME analysisSPME analysis Fiber : DVB/Carboxen/PSME (Supelco Co.)
Sample equilibration time
- incubation temp. 85℃
- incubation time 30 min
Fiber: DVB / Carboxen / PSME (Supelco Co.)
Sample equilibration time
incubation temp. 85 ℃
-incubation time 30 min


SPC-SNU 72-3SPC-SNU 72-3 KACC11451KACC11451 LallemandLallemand L73 L73
%% SDSD %% SDSD %% SDSD alcoholsalcohols Ethyl alcoholEthyl alcohol 0.260.26 0.040.04 0.210.21 0.040.04 0.280.28 0.020.02 1-One- PentanolPentanol 3.093.09 0.060.06 3.393.39 0.080.08 3.593.59 0.140.14 3-Methyl-1-3-Methyl-1- butanolbutanol 0.840.84 0.090.09 0.780.78 0.200.20 1.011.01 0.160.16 1-One- HexanolHexanol 45.6145.61 0.830.83 43.9143.91 3.053.05 30.8730.87 4.434.43 1-One- HeptanolHeptanol 1.431.43 0.370.37 1.641.64 0.600.60 1.571.57 0.190.19 2-2- EthylhexanolEthylhexanol 2.242.24 0.430.43 2.422.42 0.150.15 2.492.49 0.450.45 1-One- OctanolOctanol 0.820.82 0.270.27 1.211.21 0.400.40 1.351.35 0.170.17 1-One- NonanolNonanol 1.731.73 0.190.19 1.291.29 0.460.46 2.422.42 0.380.38 aldehydesaldehydes HexanalHexanal 19.3419.34 0.070.07 20.7220.72 0.220.22 27.4427.44 4.754.75 (E)-2-(E) -2- HeptenalHeptenal 5.465.46 0.610.61 4.084.08 0.630.63 5.315.31 0.550.55 2-2- OctenalOctenal 5.175.17 0.360.36 6.736.73 0.450.45 5.355.35 0.010.01 NonenalNonenal 0.880.88 0.110.11 1.061.06 0.090.09 0.820.82 0.480.48 BenzaldehydeBenzaldehyde 0.550.55 0.010.01 0.500.50 0.130.13 0.750.75 0.080.08 ketonesketones 2-2- HeptanoneHeptanone 0.590.59 0.510.51 0.430.43 0.120.12 1.581.58 0.290.29 AcetoinAcetoin 3.113.11 0.190.19 0.500.50 0.090.09 1.191.19 0.090.09 2-2- OctanoneOctanone 0.910.91 0.160.16 0.410.41 0.140.14 1.031.03 0.170.17 Phenyl methyl ketonePhenyl methyl ketone 0.960.96 0.120.12 0.810.81 1.001.00 1.501.50 0.030.03 acidsacids HexanoicHexanoic acid acid 5.675.67 0.690.69 8.368.36 0.460.46 9.919.91 1.401.40 etcetc 2-2- PentylfuranPentylfuran 1.321.32 0.190.19 1.551.55 0.350.35 1.541.54 0.250.25 sumsum 100100 -- 100100 -- 100100 --

* 대표적 향기 성분 19종 [Alcohol (8종), Aldehyde (5종), Ketone (4종), Acid (1종), 기타 (1종)] 에 대해서 각 성분의 상대적 비율을 백분율로 나타냈다.* Relative proportions of each component were shown as percentages for 19 representative fragrance components [Alcohol (8), Aldehyde (5), Ketone (4), Acid (1), and others (1).

마) 관능 평가E) sensory evaluation

대조구(상업적 이스트만 적용된 빵), 분리균주가 적용된 빵, 상업균주(Lallemand L73)가 적용된 빵, 공시균주(Lb. plantarum KACC11451)가 적용된 빵의 관능 평가 결과, 유산균을 적용한 실험구에서는 대조구에 비해 부드러운 식감과 풍미면에서 우수한 평가를 받았다. 유산균을 첨가한 실험구에서의 비교평가에서는 큰 차이를 보이지는 않았지만 전반적인 평가에서는 분리균주 SPC-SNU 72-3을 적용한 빵이 가장 높은 평가를 받았다.Sensory evaluation of control (bread with commercial yeast only), bread with separate strain, bread with commercial strain (Lallemand L73), and bread with test strain ( Lb. plantarum KACC11451) showed that the experimental group with lactic acid bacteria was softer than the control. Excellent evaluation in terms of texture and flavor. In the experimental group added with lactic acid bacteria, there was no significant difference, but in the overall evaluation, the bread applied with the isolate strain SPC-SNU 72-3 received the highest rating.

기탁기관명 : 한국생명공학연구원Depositary: Korea Research Institute of Bioscience and Biotechnology

수탁번호 : KCTC13316BPAccession number: KCTC13316BP

수탁일자 : 2017824Trust Date: 2017824

Claims (3)

pH 3.0에서도 산 내성을 나타내는 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP).
Lactobacillus plantarum SPC-SNU 72-3 (KCTC13316BP) exhibiting acid resistance even at pH 3.0.
제1항의 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)을 밀가루에 첨가한 후 발효시켜 제조된 것을 특징으로 하는 제빵용 반죽물.
Claim 1 Lactobacillus plantarum ( Lactobacillus plantarum ) Baking dough, characterized in that the fermentation after adding SPC-SNU 72-3 (KCTC13316BP) to flour and prepared.
제1항의 락토바실러스 플란타룸(Lactobacillus plantarum) SPC-SNU 72-3 (KCTC13316BP)을 밀가루에 첨가한 후 발효시키고, 베이킹(baking)하여 제조된 것을 특징으로 하는 빵.
Claim 1 Lactobacillus plantarum ( Lactobacillus plantarum ) SPC-SNU 72-3 (KCTC13316BP) is added to flour, fermented and baked.
KR1020180164289A 2018-12-18 2018-12-18 Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality KR102059625B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020180164289A KR102059625B1 (en) 2018-12-18 2018-12-18 Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180164289A KR102059625B1 (en) 2018-12-18 2018-12-18 Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality

Publications (1)

Publication Number Publication Date
KR102059625B1 true KR102059625B1 (en) 2019-12-26

Family

ID=69103458

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180164289A KR102059625B1 (en) 2018-12-18 2018-12-18 Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality

Country Status (1)

Country Link
KR (1) KR102059625B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058614A1 (en) 2005-11-17 2007-05-24 Celac Sweden Ab Probiotic bread and method of its production
KR100747754B1 (en) 2006-02-28 2007-08-08 정명희 Lactobacillus plantarum se 1 useful for manufacturing lactobacillus containing bread
KR101551837B1 (en) 2015-05-22 2015-09-09 에스피씨 주식회사 Natural lactic acid bacteria isolated from Korean traditional nuruk to be used for bakery
KR101551836B1 (en) 2015-05-22 2015-09-09 에스피씨 주식회사 Natural lactic acid bacteria isolated from Korean traditional nuruk to be used for bakery

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007058614A1 (en) 2005-11-17 2007-05-24 Celac Sweden Ab Probiotic bread and method of its production
KR100747754B1 (en) 2006-02-28 2007-08-08 정명희 Lactobacillus plantarum se 1 useful for manufacturing lactobacillus containing bread
KR101551837B1 (en) 2015-05-22 2015-09-09 에스피씨 주식회사 Natural lactic acid bacteria isolated from Korean traditional nuruk to be used for bakery
KR101551836B1 (en) 2015-05-22 2015-09-09 에스피씨 주식회사 Natural lactic acid bacteria isolated from Korean traditional nuruk to be used for bakery

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GRAS Notice (GRN) No. 685(2016.12.)*
Journal of Cereal Science, Vol.42, pp.300-308(2005.)*

Similar Documents

Publication Publication Date Title
AU2018423072B2 (en) Strain of Lactobacillus plantarum for fermenting and use thereof
Torres-Maravilla et al. Identification of novel anti-inflammatory probiotic strains isolated from pulque
KR101500974B1 (en) Lactobacillus plantarum HAC01 having anti-inflammation and metabolic disease improvement effect and uses thereof
KR100747754B1 (en) Lactobacillus plantarum se 1 useful for manufacturing lactobacillus containing bread
AU2003252888B2 (en) Acid- and bile salt-resistant Lactobacillus isolates having the ability to lower and assimilate cholesterol
JP5314421B2 (en) Culture method of lactic acid bacteria with high immunomodulating activity
US8372392B2 (en) Lactobacillus paracasei strain LT12 as immunity regulatory agent
EP1743042B1 (en) Lactic acid bacteria strains exhibiting probiotic properties and compositions comprising the same
US10265352B2 (en) Lactic acid bacteria, natural immunoactivator and infection preventative/therapeutic derived from said lactic acid bacteria, and food/beverage
KR101729478B1 (en) Immune regulating tyndalized lactic acid bacteria and a method for manufacturing the same
KR20180118363A (en) Lactobacillus plantarum having anti-inflammation and metabolic disease improvement effect and uses thereof
US10098916B2 (en) Strains of the genus Lactobacillus and use thereof
KR102059625B1 (en) Probiotic lactic acid bacteria with outstanding biotransformation enzyme activity, immune-modulatory activity, antimicrobial activity, and baking quality
KR102059624B1 (en) Probiotic lactic acid bacteria with outstanding immune-modulatory activity, intestinal attachment ability, and baking quality
KR102059623B1 (en) Probiotic lactic acid bacteria with outstanding baking quality and immune activity
EP1424075A2 (en) Acid and bile-resistant lactobacillus isolates having the ability to lower and addimilate cholesterol
KR102001992B1 (en) Pediococcus acidilactici SRCM102607 strain having immunity activity, antiviral activity and probiotics properties and uses thereof
JP2015073483A (en) Lactic acid bacteria which has adhesiveness to alimentary canal mucosa
KR101544180B1 (en) Novel Lactobacillus plantarum strains having high-productivity of conjugated linoleic acid, and probiotics and conjugated linoleic acid enhanced food prepared by using the strains
KR20230066110A (en) Lactobacillus delbruecki subspecies lactis LDL557 isolate, composition containing the same and use thereof
Denkova et al. Biochemical and technological properties of Lactobacillus plantarum X2 from naturally fermented sourdough
KR101518866B1 (en) Lactobacillus plantarum and use thereof
KR102582095B1 (en) Limosilactobacillus fermentum SPC L751 with excellent probiotic and baking properties
KR20150088588A (en) Novel Gamma-Amino Butyric Acid Producing Strain of Lactobacillus Brevis CFM11 and Use of the Same
WO2024090413A1 (en) Lactic acid bacterium, natural immunoactivator derived from said lactic acid bacterium, and food containing said lactic acid bacterium

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right
GRNT Written decision to grant